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Amyloidogenic peptides aggregate through a well-defined pathway to form amyloid fibrils. 
Many amyloidogenic peptides are known to toxic through the formation of fibrillar, and pre-
fibrillar aggregates. Amyloid-Beta is the most well researched amyloidogenic peptide due to its 
implications in the neurodegenerative disease, Alzheimer’s Disease. While the specific 
mechanisms for Amyloid Beta induced toxicity are not fully elucidated, membrane interactions 
are considered to be a significant component to their toxicity. 
 
Functional amyloids are amyloidogenic peptides that exhibit functional roles for the organism 
that produces it. Many peptide hormones are classed as functional amyloids as they form fibrils 
in the dense-core secretory granules. As more and more peptides are classified as functional 
amyloids, a gap in our understanding of what constitutes an amyloidogenic peptide to induce 
toxicity, or to elicit a non-toxic functional role became apparent. One theory proposes that the 
critical difference between the two amyloids are in the way they interact with membranes.  
 
Characterising membrane interactions in a live cell is exceptionally challenging to undertake 
due to the complex and dynamic nature of cellular membranes. Spectral phasor analysis can 
elucidate the spectral properties of individual fluorescent probes and can be used to correlate 
spectral changes with changes to the probes’ local microenvironment. Here spectral phasor 
analysis was tested to see if it can deduce changes in the spectral properties of the lipophilic 
xiv 
 
dye Nile Red in the presence of monomeric and aggregated forms of Amyloid Beta and 
Neurokinin B.  
 
Spectral phasor analysis was done on Nile Red to see if the technique can elucidate discrete 
spectral properties based on its subcellular location. Discrete microenvironments expressed via 
λmax and spectral width of Nile Red emission spectra were isolated in the plasma membrane, 
perinuclear, and nuclear region. Using varying sized cursors confirm that minor spectral shifts in 
Nile Red emission were detectable via spectral phasor analysis.  
 
Analysis of plasma membrane Nile Red in the presence of monomeric Amyloid Beta and 
Neurokinin B reveal spectral shifts that became discrete over time. λmax values in the presence of 
both peptides were similar at 14 hrs but became distinct at 24 hrs. Shifts in emission spectra in 
the presence of aggregated Amyloid Beta and Neurokinin B showed an opposite trend with 
λmax values became similar over time. This confirms that the plasma membrane interacts 
differently to each peptide and its aggregate over time.  
 
Spectral phasor analysis can characterise spectral shifts of a fluorescent probe at a pixel by 
pixel resolution.  Future development would allow for these discrete changes to be linked to a 
specific membrane interaction, allowing the use of spectral phasor analysis tied with Nile Red to 




Chapter 1 – Literature Review 
Amyloid was first coined in 1854 by German scientist Rudolph Virchow when he discovered 
brain deposits that stained blue when treated with iodine, suggesting that they were starch in 
nature. In 1859, Friedreich and Kekule demonstrated that these amyloid aggregates were 
composed of protein instead of carbohydrates, but still termed them as amyloid. Since then, 
various amyloids have been discovered and are associated with approximately 50 diseases, 
importantly Alzheimer’s Disease, the most common form of dementia. As a result, research 
focused on understanding the mechanisms of amyloid formation and its toxicity.  
 
1.1 – Amyloid structure 
Amyloid fibrils appear as unbranched filaments 10-20 nm in diameter and can span several 
micrometres in length1. The classical structure of the amyloid fibril core is composed of two 
tightly packed β-sheets where the β-strands align perpendicularly to the fibril axis2. Atomic 
resolution X-ray and cryo-electron microscopy derived structures of amyloid fibrils describe the 
orientation of the two sheets to be of a steric zipper motif3, 4 (Figure 1.1). Hydrogen bonding 
formed along the peptide backbone, running along the fibril axis and various side-chain 
interactions (such as π-π stacking by tyrosine resides) contribute to the fibril’s high stability2. This 
structural design is considered to be the classical amyloid structure but slight variations to this 
model have been recently identified. Using X-ray diffraction studies, Tayb-Fligelman et al.5 




Staphylococcus aureus have a cross-α structure. This structural motif still allowed the binding of 
Thioflavin T (ThT), a dye that fluoresces when bound to amyloid fibrils, and did not bear any 
morphological or staining differences to the common cross-β architecture. 
 
Amyloidogenic peptides do not bear any obvious sequence similarity to each another, but they 
do share features that contribute in their ability to aggregate6, 7. Hydrophobic regions including 
aromatic amino acids such as phenylalanine contribute to its folding. The length of the peptide 
sequence is also believed to be a factor for their propensity to aggregate. Using ThT 
fluorescence and polymerisation models Baldwin et al8 showed that peptides that have a 
sequence length approximately 100 residues or lower were more likely to form amyloids, as the 
subsequent fibrillar structure was predicted to be more stable, and the process of aggregation 
produces more energy compared to longer peptides.   
Figure 1.1. Structure of fibrillar Aβ1-42 as determined by cryo-EM.  
(A) 3D reconstruction from cryo-EM images. (B) Atomic model showing parallel cross-β structure. (C) Cross section 




1.2 – Amyloid aggregation 
Aggregation of amyloidogenic peptides follows a nucleation dependent mechanism comprised 
of three phases: an initial lag, growth, and plateau phase (Figure 1.2). In the lag phase, soluble 
monomers spontaneously coalesce and form a heterogenous array of oligomeric species2. 
Oligomers vary based on size, shape, compactness, stability and secondary structure, known as 
oligomer polymorphism9. These oligomers initially possess no secondary structure but undergo 
a structural rearrangement into β-sheet rich oligomers that can bind ThT and other amyloid-
specific dyes. Many amyloidogenic peptides are known to produce on- and off-pathway 
oligomers. Generally, off-pathway oligomers exhibit limited or negligible β-sheet content and do 
not participate in fibril formation, while on-pathway oligomers display the characteristic 
structural features and act as the building blocks for amyloid fibrils9. Both on and off-pathway 
oligomers can be formed interchangeably through varying solution conditions.  
 
In the subsequent growth phase, oligomers rapidly elongate to form protofibrils and mature 
fibrils. Protofibrils are thinner (~<10 nm in diameter), shorter (~<400 nm in length), and have a 
lower ThT fluorescence1 than mature fibrils. This elongation process is reported to be linear and 
occur unidirectionally10, where the end of one side of the protofibril acts as a molecular seed, 
recruiting and converting soluble monomers. In the plateau phase, monomeric pools of the 















Aggregation is concentration dependent and can vary based on the peptide’s critical oligomer 
concentration (COC) and the critical fibril concentration (CFC)9. In solution, monomer 
concentrations increase until reaching the COC. Upon reaching the COC, monomer 
concentrations increase at a reduced rate, promoting further fibril formation. Kinetically, the 
aggregation process is irreversible; oligomers can aggregate into fibrils, but mature fibrils 
cannot spontaneously break up into oligomers. However, protofibrils do have the potential to 





Figure 1.2. Amyloid aggregation curve. 
(A) In the initial lag phase, monomeric peptides present in solution exhibit a disordered state until they 
spontaneously coalesce and form oligomers (B) which adopt a β- strand secondary structure (red arrows). As more 
oligomers are formed, they begin to form long protofibrillar structures (C). The ends of the protofibrils act as a 
template for any local monomers to adopt the β-strand structure. (D) Eventually mature fibrils are formed when 




oligomers that are produced during the lag phase and may constitute a mechanism of toxicity 
for amyloid fibrils9. 
 
The main aggregation pathway is relatively slow and entirely dependent on the local monomer 
concentrations. Secondary aggregation pathways occur in parallel to fibril elongation and 
significantly increase the rate of fibril formation. Two known secondary aggregation pathways 
are fragmentation and secondary nucleation. Fragmentation breaks up protofibrillar or newly 
created fibrils, producing a large pool of smaller protofibrillar aggregates with increased 
nucleation sites, which accelerate the conversion of any remaining monomeric and oligomeric 
aggregates. Fibrils undergo a structural transition upon reaching the CFC, inhibiting further 
fragmentation11. Secondary nucleation processes utilise the surfaces of existing mature fibrils to 
catalyse the nucleation and formation of new fibrils. These secondary aggregation pathways 









1.2.1 – Dyes used to measure aggregation of amyloidogenic peptides 
1.2.1.1 – Thioflavin T  
Thioflavin T (ThT) was first demonstrated by Vassar and Culling (Vassar and Culling) in 1959 in 
its potential as a fluorescent probe for amyloid fibrils. Thioflavin T is comprised of a benzylamine 
and benzathiole ring, connected through a single C-C bond (Figure 1.3). This conformation 
allows for the two rings to rotate relative to each other and have different fluorescence spectral 
properties based on the rotation of the rings. Unbound ThT has an excitation and emission 
maximum of 385 nm, and 445 nm and excitation emit low fluorescence, as the rings are not 
rotationally locked12. When ThT is bound to amyloid fibrils, the two rings are rotationally locked, 
and there is a shift of the excitation and emission maximum to 450 nm and 482 nm respectively. 





ThT fluorescence is a popular method of measuring amyloid aggregation12, 13. Krebs et al.13 
characterised the molecular interactions of ThT with amyloid fibrils and deduced that ThT aligns 
parallel to the long axis of the fibril with the spaces or channels in the β-sheets. While ThT can 
bind to a large variety of amyloid fibrils, it does exhibit some level of amino acid specificity, in 
particular hydrophobic aromatic amino acids such as Tyr and Phe. Increasing evidence, 
however, has shown that ThT can bind to other non-amyloidogenic molecules such as DNA14, 





Figure 1.3. Structure and binding characteristics of ThT. 
(A) Structure and dimensions of ThT. Structure was made using ChemDraw. (B) Mechanisms of ThT binding to a β-sheet. It is believed 
that ThT binds with its long axis parallel to the spaces of the β-sheet caused by spaces made by side chain residues. This is indicated by 
the arrow. (C) Schematic describing binding of multiple ThT molecules to an amyloid fibril. Grey double headed arrows represent 





1.2.1.2 – Congo Red 
Congo Red (CR) was first synthesized by Paul Böttiger as a direct dye for cotton. In 1922, Hans 
Hermann Bennhold used CR for diagnosis of amyloidosis. In 1927, Belgian neuropathologist Paul 
Divry noticed that CR gives a green birefringence when bound to amyloid deposits16, 17.  
 
Binding of CR to amyloid deposits induces a characteristic shift in CR’s maximal absorbance 
from 490 to 540 nm. Unlike ThT, the specific molecular mechanisms of CR binding to amyloid 
fibrils is not well understood. Two models have been proposed for CR binding. One model 
proposes that CR lies parallel to the direction of the amyloid fibril, but perpendicular to the 
direction of the polypeptide chain, just like ThT16. The second model proposes that CR aligns 
parallel to the peptide chain but perpendicular to the direction of the amyloid fibril16. 
 
CR is primarily used for confirmation of amyloid aggregates in animal models and in vitro. 
However, CR has been shown to block aggregation18 and toxicity of the Amyloid Beta peptide in 
rat hippocampal neurons19, 20, human macrophage cells21, and HeLa, and PC12 cells22. 
 
1.2.1.3 – TPE-TPP  
Bis(triphenylphosphonium) tetraphenylethene (TPE-TPP) is a novel fluorescent dye initially 
reported by Leung et al.23 to have aggregation induced emission (AIE) properties. Dyes with AIE 
properties eliminate the effects of aggregation-caused quenching (ACQ), a phenomenon 
where fluorescent molecules exhibit decreasing fluorescence intensity as the fluorescent 




mechanisms to amyloid fibrils as ThT, with a higher binding affinity than the latter. Unlike ThT, 
TPE-TPP has been reported to bind to oligomeric species of amyloidogenic peptides and can 












B) C) D) 
Figure 1.4. Structure and binding characteristics of TPE-TPP. 
(A) Structure of TPE-TPP. TPE-TPP exhibits various changes in fluorescent polarization (FP) based on the type of pre-
fibrillar aggregates that are produced. FP curves for (B) reduced and carboxymethylated (RCM) a-LA, (C) RCM κ-




1.3 – Biological membranes 
Biological membranes maintain an internal environment distinct to the external environment. 
Plasma membranes serve as the first point of communication between the intracellular and 
extracellular environments and have roles such as cell to cell and cell to environment 
interactions including cell signalling, adhesion and the movement of ions and molecules in and 
out of the cell26. The integral roles of the membrane are in part maintained through the 
complexity of the membrane itself; cellular membranes are made up of a highly complex 
arrangement of lipids, proteins, sugars, and other macromolecules. Generally, cellular 
membranes consist of 50% lipids, 40% proteins, 2-10% sugars, and small amounts of water, 
inorganic salts, and metal ions26, but membrane composition drastically varies, depending on 
cell type27, 28, state29, local and physiological environment29, 30, and disease state31-33. 
 
Many models have been proposed throughout the years to describe the nature of biological 
membranes. The original lipid bilayer model was proposed by Gorter and Grendel in 192534 and 
was updated by the fluid mosaic model proposed by Singer and Nicolson in 197235. Since then, 
the model had been refined to include the presence and effects of the extracellular matrix, 
cytoskeletal proteins, membrane mobility33, and the presence of a larger composition of 
transmembrane proteins36.  
 
The lipid raft model first proposed by Simons and Ikonen37 in 1997, described that the plasma 




specific composition of lipids and proteins to confer specific functions and roles. These lipid 
rafts are generally more stable compared to other membrane regions and are rich in 
sphingomyelin, cholesterol and receptors associated with cell-signalling processes26, 37. Despite 
the lipid raft model being the most populous and considered to be the most accurate 
description of the lateral heterogeneity in cellular membranes, other models have been 
proposed. These include the picket fence model, the active actin aster model, and the phase 
switching model. These models have been reviewed in detail by Ma et al.38 
 
1.4 – Amyloid Beta 
Amyloid Beta (Aβ) is the most studied amyloidogenic peptide, as it is synonymous with the  
neurodegenerative Alzheimer’s Disease (AD), the most common form of dementia worldwide. 
Amyloid Beta is the product of the enzymatic cleavage of the amyloid precursor protein (APP) 
via β- and γ-secretase. APP is a type I single transmembrane protein expressed in GABAergic 
neurons and microglial cells and comprises of a large extracellular domain and a short 
cytoplasmic tail. Other APP-like proteins have been discovered, but the Aβ sequence is only 
present in APP39, 40.  
 
APP undergoes two major processing pathways: the amyloidogenic pathway, producing 
fragments of Aβ including Aβ1-40 and Aβ1-42 via β- and γ-secretase, and the non-amyloidogenic 
pathway, producing the non-toxic p3 fragment via α- and γ-secretase. Regulation of both 




promotes the non-amyloidogenic pathway, while APP retained in acidic compartments 
promote the amyloidogenic pathway39, 40.  
 
Researchers were initially unable to determine which aggregate was the causative agent for the 
neurodegeneration found in AD41, 42. Early studies showed that fibrillar Aβ were the primary 
causative agent20, 43, 44; however observations of neuronal injury before fibrillar deposition were 
found in AD mouse and drosophila models45, which prompted ideas that pre-fibrillar 
aggregates could be the more toxic form of Aβ. The identification of soluble, oligomeric Aβ46-48 
and their ability to disrupt cognitive function47, 49, 50 led to general shift in consensus that the 
soluble, oligomeric forms of Aβ were the primary causative agent in AD. Both fibrillar and 
protofibrillar Aβ are still recognised (although still highly contented) as toxic forms of the 
peptide. 
 
1.4.1 – Membrane interactions as mechanisms of Aβ toxicity 
Despite our limited understanding of the exact mechanisms of Aβ toxicity, it is known that 
membrane interactions are critical in its toxicity. Aβ1-40 and Aβ1-42 induces toxicity through various 






1.4.1.1 – Toxicity via intracellular calcium dysregulation  
The primary mechanism of Aβ membrane-mediated toxicity is intracellular calcium 
dysregulation, which occurs either through the formation of calcium-permeable pores, or the 
activation of calcium-permeable receptors. Pollard and colleagues51 first proposed that Aβ 
induces toxicity through the formation of calcium-permeable pores in the plasma membrane. 
The formation of these pores induces sudden calcium influxes into the cell, drastically elevating 
concentrations of cytosolic calcium (Figure 1.7). Elevated concentrations of cytosolic calcium 
initiate apoptosis through mitochondrial disruption52. In excitatory neurons, chronic elevated 
cytosolic calcium alters the balance between vesicle turnover and release, leading to synaptic 
failure. Schauerte et al.53 showed that the formation of pores at physiological concentrations of 
Aβ1-42 do not induce significant membrane disruption. 
 
The mechanism of the process is not entirely understood, but a few potential steps have been 
identified. Interacting with lipids promotes Aβ to adopt a β-sheet conformation, which is critical 
for the formation of oligomeric pores54. Electrostatic interactions are critical in determining 
whether species of Aβ forms pores. The C-terminus region is the primary driving force for Aβ 
insertion as reported in several studies55, 56 while the N-terminal region remains absorbed on the 
membrane57. Interactions between side chains and the lipid headgroups promote membrane 




Upon membrane insertion, the process of pore formation is believed to be highly dynamic, and 
the stability of the pore itself is based on the orientation of the peptide at the initial interaction 
step59. Through modelling simulations Mobley et al.55 showed that Aβ1-40 and Aβ1-42 can have 
three different insertion conformations: transbilayer, fully, and partially inserted. In the 
transbilayer conformation the peptide is completely inserted within the bilayer, with the C-
terminus anchored to the inner leaflet. The fully inserted conformation is like the transbilayer 
conformation, but the last residues are not anchored to the inner leaflet. In the partially inserted 
conformation, most of the peptide is associated with the outer leaflet. The authors conclude that 
Aβ1-42 would most likely undergo a partial insertion as it was determined to promote pore 
formation more easily compared to the other conformations (Figure 1.5). 
 
 
Figure 1.5. Three different insertion models for Aβ peptides.  
Transbilayer conformation. Peptide is completely inserted into the membrane, with the C-terminus attached to the 
inner leaflet. (B) Fully inserted conformation. Like the transbilayer conformation, but the C-terminus is not attached 
to the inner leaflet and is more free-flowing. (C) Partially inserted conformation. Majority of the peptide is either 




Using molecular dynamics simulations Jang et al.59  proposed two potential pore topologies: 
one where the N-terminus is facing inwards towards the pore, and the C-terminus is facing 
outwards towards the bilayer, and another topology where the C-terminus is facing inwards, 
while the N-terminus is facing outwards (Figure 1.6). They showed that the latter topology is the 
more stable conformation and is necessary to create a stable calcium-permeable pore. Ullah 
and colleagues60 showed that during the initial stages, pores of various sizes are formed and 










Oligomeric Aβ interacts with the ionotropic glutamate N-methyl-D-aspartate (NMDA) and the 
GluA2 variant of the amino-2-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor, 
making them calcium-permeable and inducing intracellular calcium dysregulation61-66 in AD. 
Additionally, endocytosis of both receptors has been reported to induce neuronal death 
through aberrations in synaptic processes67-70.  
A) B) 
Figure 1.6. Modelling simulations of Aβ ion channels. 
Two different channel topologies were tested in their stability in simulated DOPC bilayers from 0 – 30ns. (A) CNpNC 
conformation has the C-terminus facing outwards towards the bilayer while the N-terminus faces inwards. (B) NCpCN 
conformation has the C-terminus facing inwards, while the N-terminus faces outwards towards the bilayer. Image 




1.4.1.2 – Other receptor interactions 
Oligomeric Aβ activates the receptor tyrosine kinase p75 neurotrophin receptor (p75NTR)71. 
P75NTR mediated Aβ toxicity involves downstream signalling of p38 and JNK proteins, leading 
to subsequent activation of p53 through nuclear translocation of nuclear factor-κB (NF-κB)72. 
 
The receptor for advanced glycation end products (RAGE) is a receptor for several signalling 
molecules and induces many diverse cell signalling pathways, including apoptosis. Aβ interacts 
with microglial RAGE to promote activation73 and neuronal RAGE to induce endocytosis and 
intracellular accumulation of Aβ74.  
 
Oligomeric Aβ can bind to the cellular prion protein (PrPc)75, 76. This interaction is mediated by the 
N-terminal region (NTR) of PrPc and can lead to two varying effects. The first is activation of the 
metabotropic glutamate receptor 5 (mGluR5) and Fyn kinase leading to deficits in long term 
depression (LTD) which induces impairment in synaptic plasticity77. The second effect is 
promoting membrane insertion and pore-formation, leading to intracellular calcium overload, 
vesicle release, and synaptic failure77. The interaction of oligomeric Aβ with PrPc induces tau 








1.4.1.3 – Adsorption and membrane thinning  
Adsorption to lipid bilayers is thought to be critical for the formation and elongation of 
protofibrillar Aβ1-4278. Adsorbed monomeric Aβ1-42 adopts a β-sheet secondary structure and 
attach to the ends of the growing protofibrils, extracting the membrane lipid off the bilayer in the 
process. This leads to an overall thinning and destabilisation of the lipid bilayer in a detergent-
like mechanism79.  
 
Aβ’s affinity towards membranes is dependent on the aggregate and lipid type. Monomeric Aβ1-
42 adsorbs quickly and reversibly onto lipid bilayers, while aggregate Aβ1-42 adsorb slowly but 
irreversibly80. Chi et al.78 showed that aggregation is promoted through adsorption onto anionic 
lipids. Cholesterol promoted Aβ1-42 adsorption by preventing membrane insertion81-83.  
 
Both pore formation and protofibrillar elongation involve associations with lipid bilayers, but 
whether these processes are separate or linked is poorly understood. Sciacca et al.84 showed 
that Aβ1-40 pores were unstable and were not present when fibril formation was complete. They 
imply that the growing protofibrillar recruits both absorbed β-sheet rich Aβ monomers and 
inserted Aβ oligomers. Despite the observations, they were unable to conclusively determine 



























Figure 1.7. Amyloid Beta membrane interactions. 
(A) Oligomeric Aβ interact with ionotropic glutamate receptors such as the NMDA and AMPA receptor to induce 
calcium influxes, or receptor tyrosine kinases such as the p75 neurotrophin receptor to induce intracellular signalling 
cascades leading to apoptosis. (B) Conversely, Aβ can absorb onto the membrane itself to form calcium-permeable 




1.4.1.4 – Direct mitochondrial dysfunction 
Intracellular accumulation of Aβ can occur through endocytosis via receptors like RAGE74 or 
through enzymatic processing of APP39. Aβ enter mitochondria through the outer mitochondrial 
membrane translocase (TOM40) and the inner mitochondrial membrane translocase (TIM22)85 . 
Upon entering mitochondria, Aβ induces reactive oxygen species (ROS) production85. Aβ can 
interact with proteins associated with the mitochondrial permeability transition pore (MPTP), 
complexes IV and V, ATP synthase, and proteins associated with cytochrome C oxidase 
activity85. All these interactions lead to mitochondrial dysfunction, the release of cytochrome C 
into the cytoplasm and the initiation of the caspase cascade through caspase-3 activation52, 85, 86.  
 
1.5 – Functional amyloids 
An increasing number of amyloidogenic proteins have been discovered to participate in 
physiological processes. These amyloidogenic proteins are known as functional amyloids. Many 
functional amyloids are also considered to be non-toxic. Bacterial amyloid fibrils composed of 
proteins produced by Escherichia coli, Bacillus subtilis, and Pseudomonas, Salmonella, 
Citrobacter, and Enterobacter species assist in biofilm production and promote cell-cell and 
cell-surface interaction87. In humans, the melanocyte protein Pmel17 forms amyloids during the 
early stages of melanosome maturation to promote melanin synthesis through the acceleration 
of the polymerisation of precursor molecules and sequestration of toxic precursors out of the 
melanosome88. Several peptide hormones form amyloids when packed into secretory granules 




1.5.1 – Neurokinin B 
Neurokinin B (NKB; Neuromedin K) is a 10-residue copper-binding neuropeptide that belongs to 
the tachykinin family of peptides. Tachykinins are found throughout the human body and have 
numerous roles. NKB is primarily involved in reproductive endocrinology where it helps shape 
pulses of gonadotrophin-releasing hormone (GnRH) indirectly via modulating secretion of 
kisspeptin. To achieve this, NKB interacts with the neurokinin receptor type 3 (NK3R)90. NKB and 
NK3R have also been attributed to conditions such as hypertension, and pre-eclampsia91.  
 
NKB was identified by Maji et al.89 to be one of several pituitary peptides and hormones that 
form fibrils in dense-core secretory granules. Amyloid formation in these vesicles is thought to 
allow packing of a high concentration of peptide in the granule. The primary sequence of NKB is 
similar to the 12-28 region of Aβ, which is thought to be the amyloidogenic core of the protein. 
NKB was experimentally shown to aggregate faster than Aβ and its fibrils were found to be non-
toxic92. Co-incubation with NKB ameliorates the toxic effects of Aβ93. The non-toxic nature of 







1.6 – Current theories to explain differences between toxic and 
functional amyloids 
As the concept of functional amyloids is becoming widely recognised, questions have arisen on 
our understanding of these two types of amyloids, mainly, what constitutes a peptide to form a 
functional or toxic amyloid? Are the differences between the two protein types based on 
differences in their primary sequence or aggregation kinetics? Are the types of aggregates 
formed from a functional and toxic amyloidogenic peptide structurally different? Do all 
amyloidogenic peptides have functional roles at low concentrations, but become toxic as 
concentration of the peptide increase? 
 
1.6.1 – Production of functional amyloids is tightly controlled, and they are 
easily eliminated  
Evidence has suggested that functional amyloids exhibit no cellular toxicity due to a highly 
regulated aggregation process. Using ThT and intrinsic tryptophan fluorescence, Pfefferkorn 
and colleagues94 showed that aggregation of the repeat domain (RPT) of Pmel17 was 
preferable in a low pH microenvironment, which is typically found in early melanosomes. They 
also showed that at a neutral pH microenvironment, reminiscent of late-stage melanosomes, 
RPT failed to form fibrils and aged RPT fibrils disaggregated. This observation was confirmed 
using electron microscopy (EM) where smaller indistinct aggregates were present at pH 4, 




The pH of the intracellular microenvironment plays a critical role in regulating the fibrillization of 
many peptide hormones. For many peptide hormones packaged in secretory vesicles, the small 
space and acidic microenvironment promote their fibrillization, but as they are released into the 
extracellular space, the neutral pH and ample space promotes its disaggregation89.  
 
Impairment of Aβ clearance is believed to be a major factor in the development of AD within 
individuals. Aβis produced and secreted in the brains of healthy individuals. Most sporadic AD 
patients carry the e4 allele of the apolipoprotein E (Apo-E) gene (APOE, Apo-e4). Apo-e is 
produced by astrocytes and incorporated into lipoproteins, forming Apo-e lipoprotein 
complexes. These complexes bind soluble Aβ species and transports them to glial cells for 
internalisation and degradation. This is done via interactions with various cell-surface receptors. 
Apo-e lipoprotein complexes eject soluble Aβ out of the brain through the blood-brain barrier 
(BBB)95. Patients with the Apo-E4 allele have increased plaque deposition compared to Apo-E2, 
and Apo-E3 isoforms. Apo-E4 lipoproteins bind weakly to Aβ and disrupt cholesterol regulation 
which is known to be associated with Aβ production, indicating that the E4 allele produces a 






1.6.2 – All amyloidogenic peptides have functional roles, but become toxic 
at high concentrations or once they become fibrils 
Aβ and PrP106-126 have been shown to possess antimicrobial activities96, 97 and nanomolar 
concentrations of Alpha-Synuclein (As) may contribute positively to synaptic neurotransmission 
by promoting synaptic vesicle release98. These effects are diminished at micromolar 
concentrations of As. Fibrillar human and ovine corticotropin-releasing factor (h-CRF, o-CRF), 
human and mouse urocortin III (hUcnIII, mUcnIII), human growth hormone-releasing factor, 
glucagon-like peptide-2 (GLP-2) were found to be toxic to rat hippocampal neurons89. 
 
1.6.3 – Functional amyloids assemble faster than their toxic counterparts, 
and thus do not produce toxic oligomers 
If we consider that all amyloidogenic peptides are both functional and toxic depending on their 
concentration and aggregate state, then the oligomeric species of functional amyloidogenic 
proteins should also be toxic. However, oligomeric species of any human amyloidogenic 
peptides have not been determined or stabilised for in vitro studies. This led to the theory that 
the aggregation kinetics of functional amyloidogenic peptides favour a faster lag phase, such 
that the oligomer formation is highly transient. NKB aggregates faster than Aβ12-28 99. It is still 





1.6.4 – Membrane interactions of functional and toxic amyloids differ 
As described above, membrane interactions are considered to be a critical component to the 
toxicity of many amyloidogenic proteins, and the membrane interactions of several functional 
amyloidogenic peptides have been studied. Membrane specificity is present for several 
functional amyloid proteins. Orb2A has preferential binding to anionic membranes100, while 
Pmel17 has a higher aggregation rate in the presence of lysophospholipids101. Obestatin and 
Orb2A adopt an α-helix secondary structure upon binding to membranes. In the case of 
Obestatin, this interaction is necessary for the protein to bind to the GPR39 receptor102, while 
Orb2A aggregation is inhibited once it is bound to membranes100. 
 
1.7 – Membrane characterisation techniques 
Membrane studies have become a significant contributor to amyloid research. Studying 
membranes, especially live, cellular membranes is incredibly challenging due to their complex 
nature and composition. Several techniques have been developed to characterise membranes 
at various temporal and spatial resolutions.  
 
1.7.1 – Molecular Dynamics simulations 
MD simulations have been extensively used to understand the exact atomic mechanisms of Aβ1-
42 interactions with specific lipids and cholesterol55-59, 103-107. Molecular Dynamic (MD) simulations 
measure the movement of every atom in a carefully constructed model over a period of time. 




that is highly complex or impossible to achieve using other methods. The technique has become 
widely adopted as a result of advances in computing power and significantly reduced costs.  
 
1.7.2 – Unilamellar vesicles as model membranes 
The complex nature of biological membranes in live cells makes it extremely difficult to precisely 
identify the specific causes of a recorded observation (such as the membrane interactions of 
Aβ1-42). Many model systems for studying membranes have been developed. These systems are 
advantageous over live cells as the contents and composition of the membranes are 
controllable and are easy to mass produce. Giant unilamellar vesicles (GUVs) are vesicles 
containing a lipid bilayer and are > 1 μM in diameter (Stein 2017). GUVs are often comparable in 
size to eukaryotic cells and thus can be easily monitored under a light microscope, making it 
easier to record observations compared to large unilamellar vesicles (LUVs) and small 
unilamellar vesicles (SUVs). However, LUVs and SUVs are easier to produce, with commercial 
extrusion tubes and filters readily available for purchase. 
 
1.7.3 – Atomic Force Microscopy 
Atomic Force Microscopy (AFM) was invented in 1986 by Binnig, Quate and Gerber108. 
Principally, AFM involves a probe made of a cantilever with a tip moving along the surface of the 
sample, and vertical movement is recorded. In doing so the surface morphology and properties 
of the sample can be measured26. Samples can be imaged using AFM in their physiological 




species of Aβ1-42, reveal that enantiomers of the peptide induce structurally similar pores 105, and 
the effects of membrane composition on Aβ1-42 interactions 109-111.   
 
1.7.4 – Fluorescence Microscopy 
Fluorescence microscopy encompasses a large number of similar techniques and has become 
widely adopted in part due to increasing affordability and wide availability of microscopes, as 
well as the ever-increasing number of commercially developed fluorescent probes.  
 
In principle, fluorescence occurs when a fluorescent probe in its “ground state” is excited by 
photons at a specific energy (i.e. light at a specific wavelength). The photons give energy to the 
probe’s electrons, allowing them to jump to a higher electron orbital. The excitation process is 
temporary, and the electron relaxes back down to its ground state, in doing so releasing a 
photon. As some energy is lost during the relaxation process, the emitted photon has less 
energy and has a longer wavelength than the excitatory photon112.  
 
The potential for fluorescence microscopy to be fully utilised depends on the equipment and 
training available to researchers. Microscopes that have a limited number of lamp or lasers 
restricts the number of fluorescent probes that can be utilised. Higher quality microscopes can 





1.8 – Spectral Imaging  
Spectral imaging is the combination of imaging and spectroscopy, where the fluorescence 
intensity of an image is measured over a set of wavelengths (or wavelength bands). 
Hyperspectral imagining is an extension to spectral imaging where a large number of bands are 
utilised, allowing for an entire emission spectrum of the fluorescent probe/s in each pixel within 
an image or region of interest (ROI) to be collected. Both imaging techniques are acquired 
through what is known as an XYλ scan which scans the image on the X and Y focal plane at 
specific wavelengths, over a user-defined wavelength range. Spectral imaging allows for the 
utilisation of multiple fluorescent probes that cover a wide emission spectrum in the same 
sample113, 114.  
 
In principle, hyperspectral imaging can be utilised to measure the local microenvironment of a 
macromolecule based on changes in the spectral properties of a localised fluorescent probe. 
For example, a fluorescent probe attached to a receptor exhibits changes in its spectral 
properties when the receptor is activated compared to its inactivated form (Figure 1.8). 
Therefore, by measuring changes between the fluorescent probe’s spectral properties, we 
could indirectly assume that the receptor is either in an activated or non-activated state.  
Many fluorescent probes spectral properties (e.g. emission spectrum) are influenced by local 
environmental effects such as pH, polarity, temperature and any surrounding macromolecules. 
For example, the lipophilic stain Laurdan is known to exhibit spectral shifts depending on the 




provide us with information about the local environment of a macromolecule, based on changes 










One current limitation to the adoption of hyperspectral imaging is data analysis. Despite the 
extensive catalogue of commercial fluorescent probes that have varying excitation and 
emission spectra, it is not uncommon for multiple probes to be utilised that have overlapping 
spectra. Basic imaging would not be able to differentiate between each fluorescent probe and 
thus will need to be processed before analysis114. The linear decomposition algorithm (or linear 
unmixing) involves mathematically unmixing the spectra based on reference spectra of pure 
fluorophores. However, the process can become complicated as reference spectra have to be 
acquired (either through published literature data or other experiments) and can introduce 
A) B) 
Figure 1.8. How spectral properties confer changes in local microenvironment. 
(A) In this example, a fluorescent protein is tagged to an inactivated protein, expressing a λmax of 510 nm and 
spectral width of 100 nm. (B) When a co-factor binds to this protein, activating it, it causes the protein to undergo a 
conformational shift, which alters the location of the fluorescent protein. In doing so, the spectral properties of the 




artefacts due to environmental variations between the reference and experimental spectra 
which then results in extensive calibration115. 
 
1.9 – Spectral Phasor Analysis  
Spectral phasor analysis is an alternative processing method that allows for a fast, reliable 
method for spectral unmixing without the need of reference spectra. The emission spectra 
collected in each pixel of is Fourier transformed, and the real (amplitude) and imaginary (phase) 
components are plotted on a phasor plot, where the emission maximum (λmax) and spectral 
width of each emission spectrum can be identified. The emission maximum is plotted 
anticlockwise in increasing wavelength, and spectral width extends from the origin outwards in 
decreasing spectral width (Figure 1.9). Each pixel on the phasor plot represents a unique 

















Spectral profiles can be selected on the phasor plot using cursors. Pixels on the provided 
spectral image that share the same profiles selected by the cursor will be highlighted in the 
same colour as the cursor itself (figure 1.10). An average λmax and spectral width value will be 
displayed since a cursor selects multiple spectral profiles at once. The cursor’s shape and size 
can be modified in order to select more specific spectral profiles within the spectral image and 
𝑔𝑔 =  
∑ 𝐼𝐼(𝜆𝜆) cos(2𝜋𝜋𝜋𝜋𝜆𝜆𝐿𝐿 )𝑘𝑘
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Figure 1.9. How a spectral image and phasor plot are produced. 
(A) Each pixel in an image or region of interest is scanned at specific wavelengths at regular intervals over a range of 
wavelengths to produce an emission spectrum for each pixel.  Image adapted from Garini et al.114 This scan is known 
as a XYλ scan and all three components of the scan described above are user-defined. (B) The emission spectrum 
for each pixel is then Fourier transformed and the two components of the spectral phasor using the first harmonic, G 
and S, are calculated using the following equation. I(λ) is the fluorescence intensity at the wavelength, n is the 
harmonic number, and L is the total wavelength range. Image adapted from Golfetto et al.113 (C) G and S values are 
plotted on a phasor plot where the λ max of the emission spectra is plotted anticlockwise in increasing wavelength, 





to achieve a more accurate λmax and spectral width (Figure 1.10). Representing the data on a 
phasor plot enables the grouping of identical spectral properties, making it easier to identify 
predominant spectral properties, and to identify regions of the image with the same spectral 
properties. The predominance of a spectral profile is indicated by the colour (or intensity) of the 















Figure 1.10. How cursor size and phasor intensity are represented on a spectral image. 
(A) Colours on the phasor plot (left) indicate the spectral predominance based on the number of pixels that share the 
same spectral properties. Selecting a pixel that is blue (red cursor) will illuminate a few pixels on the spectral image 
(right), while selecting a red pixel (light green cursor) illuminates a large majority of the pixels in the same spectral 
image. Pixels are coloured from blue  green  red with increasing spectral predominance. All cursors have a size 
of 0.01. (B) Using a larger cursor (light green) to select a group of pixels of similar intensities will highlight a larger 
number of pixels on the corresponding spectral image compared to a smaller cursor (red). The red and green cursor 




Spectral phasor analysis has been applied to characterise of a number of cellular 
microenvironments, such as specific subspecies of RNA and ribonuclear protein complexes 
using Pyronin Y116, or sodium microenvironments in myoblast progenitor cells during 
differentiation117. Golfetto et al.113 measured membrane microheterogeneity and lipid domains 
using spectral phasor analysis of Laurdan fluorescence. Malacrida et al.118 showed that the 
organelle hydration properties of lamellar body like organelles in A549 cells differ significantly 
to those found in model membranes. The drought hypersensitive/squalene epoxidase 1-5 
(dry2/sqe1-5) Aranidopsis thaliana mutant was shown to have higher membrane fluidity 
compared to the wild type by spectral phasor analysis conducted by Sena et al.119. Recently, 
Sameni et al.120 showed that membrane fluidity is increased in PC12 cells expressing mutated 
HTT exon 1 indicating a mechanism of toxicity in Huntingtin disease.  
 
While spectral phasor analysis has the immense potential of simplifying hyperspectral imaging 
analysis, it does possess several caveats. These caveats primarily involve the process of 
acquiring the spectral image. A single XYλ scan can be time-consuming, and thus the 
fluorescent probe within the ROI is susceptible to photobleaching. Fluorescent probes that 
become photobleached during the scan will produce weak spectra that may unable to be 
analysed. Additionally, events that occur on a small timescale (e.g. microseconds) may be 
missed due to the long XYλ scan time. These issues can be mostly alleviated by either 
increasing the scan speed (how fast the laser scans through the ROI), decreasing the total 
number of spectral scans (how many times the ROI is scanned), or shortening the wavelength 




spectral phasor plot, the ability to identify discrete microenvironments, and potentially excluding 
important information that could have been extrapolated from a fully resolved spectra. A 
balancing act is always undertaken between obtaining a high quality or useful spectra.  
 
As spectral phasor analysis is extremely sensitive to small changes in spectral properties, other 
unrelated, physiological factors such as cell-cell or cell-environment interactions can cause 
significant spectral shifts. This can be misinterpreted as positive results. Genetically, these 
issues can be reduced through forcing cell synchronization, scanning multiple cells within a 














1.10 – Fluorescent lipophilic probes 
Membrane analysis through fluorescence microscopy and spectral imaging utilises lipophilic 
fluorescent dyes81, 121. Fluorescently tagged amyloidogenic peptides and membrane proteins 
have been utilised to measure specific membrane interactions81, 82, 122. 
 
1.10.1 – BODIPY dyes 
Boron-dipyrromethene (BODIPY) dyes are neutrally charged, but highly photostable, and 
fluorescent dyes. Because of its characteristics, BODIPY can be modified to target specific 
macromolecules, either through direct chemical modification as a tagged analog. As a result, 
there are a large number of commercial BODIPY-based probes developed that are specific to 
lipids, cholesterol, organelles (e.g. mitochondria), and specific proteins that have various 
excitation and emission profiles123. BODIPY probes can be designed to be pH sensitive or to 
fluorescence based on activation of specific biological processes. However, due to its 
hydrophobicity, lipid staining BODIPY dyes are reported to excessively accumulate in 
membrane compartments and cause cytotoxicity124. 
 
1.10.2 – Laurdan 
Laurdan (6-dodecanoyl-2-dimethylaminonaphthalene) was developed in 1981. Laurdan has a 12 
fatty acid tail, allowing it to insert within the lipid bilayer and maintain a consistent orientation 




dramatic spectral shifts in the presence of varying levels of hydrophobicity, thereby making it an 
excellent probe for characterising membrane fluidity125, 126. 
 
1.10.3 – Nile Red 
Nile Red is a Benzophenoxazone dye (Figure 1.11) first discovered in trace amounts during the 
commercial preparation of the non-fluorescent lipid dye Nile Blue. It is a hydrophobic dye that 
fluorescence intensely when bound to lipid droplets and amphipathic lipids (e.g. phospholipids). 
Nile Red undergoes a significant blue shift of its emission maxima in the presence of 
triacylglycerols and cholesterol esters127-129 (Figure 1.11). Due to its hydrophobic nature, Nile Red 
binds to proteins with hydrophobic domains such as the photoactive yellow protein130, tubulin131 
and the amyloidogenic proteins human calcitonin132, insulin, transthyretin, human prion protein, 
and Aβ133. 
 
Halder et al.134 conducted an extensive study on the effects of various lipid properties on the 
emission spectrum of Nile Red. In agreement with Fowler and Greenspan128, they showed that 
Nile Red is highly fluorescent in hydrophobic environments with blue-shifting of its emission 
maxima with increasing hydrophobicity. In terms of how lipid characteristics could affect Nile 
Red emission they concluded the following: 1) saturation states had a significant effect on 
emission, as Nile Red bound to saturated lipids experienced an higher emission maxima 
compared to unsaturated lipids, and 2) charge, head group and the length of the lipid chain had 











1.11 – Aims  
Membrane interactions have become a significant component of the toxicity of Aβ1-42 and are 
reported to be involved in the function of functional amyloidogenic peptides. However, there 
has not been a study that directly compared the membrane interactions between the two 
amyloidogenic peptide types. This study explores whether we can apply spectral phasor 
analysis to determine if Aβ1-42 and NKB induce different interactions at the membrane interface. 
This study will also assess the viability of spectral phasor analysis to characterise and 









Figure 1.11. Structure and spectral properties of Nile Red. 
(A) Structure of Nile Red. Nile Red exhibits varying excitation and emission profiles based on whether it is 
localised with phospholipids (B) or triglycerides (C). When interacting with phospholipids, its 
excitation/emission maxima (Ex/Em) is 552/636 nm, while when interacting with triglycerides it has an 





Chapter 2 – Characterisation of Nile Red 
microenvironments using Spectral Phasor Analysis 
2.1 – Introduction  
Spectral phasor analysis has been extensively applied to the lipophilic dye Laurdan because of 
its extreme sensitivity to membrane fluidity. Malacrida et al.118 showed through Laurdan spectral 
phasor analysis that the hydration levels in A549 cells differ from day to day post-confluence, 
which differ from those determined from model membranes. In a subsequent study, Malacrida 
and Gratton135 showed that hydrogen peroxide treatment to NTH-3T3 fibroblast cells 
decreased membrane fluidity but increased dipolar relaxation. Sameni et al.120 showed altered 
membrane fluidity in a huntingtin disease model. The authors verified their Laurdan spectral 
results with Nile Red. However, spectral phasor analysis has not been fully applied to the 
lipophilic dye Nile Red.  
 
This chapter investigates whether the spectral phasor analysis approach can successfully 
characterise distinct Nile Red species in live 1321N1 astrocytoma cells. Spectral properties for 
plasma membrane, perinuclear, and nuclear Nile Red were identified, and significant spectral 
shifts were present between the plasma membrane, perinuclear and nuclear Nile Red 
populations. Plasma membrane heterogeneity was observed through Nile Red spectral 
variances around the region. Therefore, the spectral characteristics of distinct Nile Red species 




2.2 – Methods  
2.2.1 – Cell culture 
1321N1 are a human astrocytoma cell line isolated in 1972 as a subclone of the cell line 1181N1 
which was isolated from the parent line U-118 MG136. 1321N1 astrocytoma cells were cultured in 
Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% Fetal Bovine Serum 
(FBS), and 0.1% penicillin/streptomycin and maintained at a 37°C, 5% CO2 incubator. Cells were 
seeded in 35mm, glass-bottom, fluorodish (World Precision Instruments) and were imaged 
once they reached 80% confluency. 
 
2.2.2 – Spectral data acquisition 
Spectral data were acquired using the Leica TCS SP5 Confocal inverted confocal microscope 
with an HC PL APO CS2 63 x 1.2 water objective paired with an Argon 561 laser. Before imaging, 
cells were treated with 40 μM Nile Red. Excitation occurred at 561 nm using 4% of maximum 
laser power. Spectral data acquisition imaged a region of interest (ROI) that was 256 x 256 in 
resolution at 12 bits. Acquisition utilised a detection bandwidth range of 570-700 nm, with a 100 






2.2.3 – Spectral Phasor Analysis 
Spectral phasor analysis was done using SimFCS 4.0 (University of California, Irvine). All X/Y/λ 
data was imported onto SimFCS 4.0, “referenced” and “read” (Appendix 1). The phasor plot was 
calibrated with a start and end wavelength of 570 and 700 nm respectively. Cursor placement 
onto the phasor plot generated λmax and spectral width values which were recorded onto  
Microsoft Excel. Both Microsoft Excel and Prism 8 were used for statistical and graphical 
representation. Statistical analysis was conducted using the post-hoc mean comparisons test 
with Dunnett T3 multiple comparisons corrections from a Brown-Forsythe and Welch one-way 
ANOVA test. Data represented as mean ± SEM. 
 
2.3 – Results   
2.3.1 – Nile Red microenvironments at discrete cellular locations revealed 
via spectral phasor analysis 
Large cursors (0.04 and 0.05) were first used to select emission profiles of Nile Red associated 
with the plasma membrane, perinuclear, and nuclear regions in 1321N1 cells (Figure 2.1). The 
average λmax and spectral width values for plasma membrane Nile Red was 616.7 ± 0.9 nm (n = 
18) and 18.2 ± 0.8 nm (n = 18). Perinuclear and nuclear Nile Red exhibited significant spectral 
shifts with a ~10nm increase in λmax [624.6 ± 0.7 nm (n = 23), and 626.4 ± 0.6 nm (n = 11)] and 
decreased spectral width [13.2 ± 0.4 nm (n = 23), and 15.9 ± 0.8 nm (n = 11)] compared to plasma 
membrane Nile Red. There was a statistically significant difference between λmax values of 




The same Nile Red emission profiles were selected with smaller cursors (0.005 and 0.01). 
Smaller cursors can select individual Nile Red spectra and identify discrete microenvironments 
at a pixel resolution. As expected, all re-analysed regions exhibited similar λmax [615.7 ± 0.4 nm (n 
= 85), 624 ± 0.2 nm (n = 66), 625.9 ± 0.2 nm (n = 70) for plasma membrane, perinuclear, and 
nuclear regions respectively] and spectral width (18.9 ± 0.2 nm (n = 85), 12.2 ± 0.1 nm (n = 66), 
and 15.4 ± 0.3 nm (n = 70) for plasma membrane, perinuclear, and nuclear regions respectively] 
values (Figure 2.2). Nile red λmax and spectral width of Nile Red in all regions were statistically 
significant to each other (p < 0.0001 for all comparisons; Appendix 2) 
A) C) B) 
D) 
Figure 2.1. Discrete spectral properties of Nile Red species in discrete cellular regions. 
(A) Fluorescence image. (B) Phasor plot with zoomed-in inset outlining all cursors used to highlight Nile Red species 
isolated in the plasma membrane (dark blue and orange), perinuclear (red and dark green) and nuclear (light green) 
regions of the cell. (C) Corresponding spectral image with regions highlighted with corresponding cursor colours. (D) 
































































































Figure 2.2. Average λmax and width values of Nile Red in discrete cellular regions. 
Spectral properties of plasma membrane, perinuclear, and nuclear Nile Red were analysed using (A) 
large and (B) small cursors. Data is expressed as column bar with mean ± SEM. Statistical analysis 
was conducted using a post-hoc mean comparisons test with Dunnett T3 multiple comparisons 




2.3.2 – Plasma membrane heterogeneity revealed through SPA 
Quantitative analysis of Nile Red microenvironments reveals that the species around the plasma 
membrane region exhibited the highest variance between the three regions (6.6 and 6.5 nm for 
λmax and width respectively). These results are corroborated from qualitative analysis of the 
phasor plots. Spectral hotspots present in all phasors highlight nuclear and perinuclear Nile Red 
and requires one or two large cursors to select them. The spectral properties of plasma 
membrane Nile Red meanwhile cover a broad region to the right of the hotspots and require the 
use of multiple large cursors to fully highlight the region (Figure 2.3; Appendix 3-4). Analysis of 
the corresponding spectral image shows the lack of any large regions of the membrane 
composed of a single Nile Red species (Figure 2.3; Appendix 3-4). What appears to be filopodia 
and/or lamellipodia are highlighted in one spectral image (Figure 2.3A) and are more 
homogenous than the typical plasma membrane. These observations are not consistent 
between cell to cell; some cells exhibit more homogeneity in their plasma membranes 
compared to others. On one cell, the plasma membrane closest to the perinuclear and nuclear 
regions were found to be more homogenous than the membrane located further out towards 
















Figure 2.3. Plasma membrane Nile Red microenvironments. 
From left to right: fluorescence image, phasor plot with inset of zoomed in plot, and spectral image. All cursor sizes 







2.3.3 – Perinuclear and nuclear Nile Red exhibit high homogeneity  
Spectral hotspots were present in all spectral phasors. These hotspots were found to highlight 
the perinuclear and nuclear regions of the cell, which is indicative that the Nile Red in these 
regions exhibit broadly similar spectral properties. The perinuclear and nuclear regions share 
relatively low spectral variance in both λmax (2.5 and 1.1 nm) and spectral width (0.3 and 1.7 nm). 
Cursor placement within the phasor plot was similar for all cells (Figure 2.4). Qualitative analysis 
of the spectral images reveals that nuclear Nile Red share the same spectral properties as 
cytoplasmic Nile Red. The spectral image also reveals that the nuclear region is 
compartmentalised into regions of identical Nile Red species (Figure 2.4). This 
compartmentalisation is present in all cells but is not identical between all cells. In all cells, Nile 
Red species located towards the centre of the nuclear region (i.e. furthest away from the 



















Figure 2.4. Nuclear Nile Red microenvironments. 
All cells displayed similar patterns of nuclear Nile Red spectra. From left to right: fluorescence image, phasor plot with 




2.4 – Discussion  
Utilising hyperspectral imaging, the emission spectrum of every fluorophore in an image can be 
acquired. As the emission spectrum is indicative of the local microenvironment of the 
fluorophore, comparisons of emission spectra of the same fluorescent probe over an image can 
give us an enhanced understanding of the molecular environment of the macromolecule that 
the fluorophore is localised with. The spectral phasor analysis is a simple quick method of 
analysing and presenting data acquired from a hyperspectral image, where the spectral 
properties in each pixel in a spectral image are grouped and plotted on a spectral phasor plot. 
Spectral phasor analysis has already been demonstrated for several dyes. No published 
literature has demonstrated the viability of Nile Red as a fluorescent probe for spectral phasor 
analysis.  
 
This study investigates whether spectral phasor analysis can be successfully applied on Nile 
Red to identify and differentiate between discrete lipid microenvironments. Hotspots on the 
phasor indicate spectral profiles that are predominant in the image. When the spectral profiles 
within a hotspot are localised to a region, it can be implied that its spectral properties within that 
region are similar and that its microenvironment is predominantly homogenous. In all samples, 
hotspots were linked to nuclear and/or perinuclear Nile Red. The perinuclear region consists of 
several vesicles and large organelles, some that are physically attached to the nuclear 
membrane, such as the endoplasmic reticulum and others located just near the nuclear 




cytoplasmic region, which can explain for the Nile Red fluorescence towards the outer 
cytoplasmic periphery.  
 
The data presented here show the presence of Nile Red bound molecules within the nuclear 
region. It is well accepted that lipids are present in the nucleoplasm. Nuclear lipids such as 
secondary messengers have critical roles in controlling proliferation and gene expression137, 138. 
Nuclear lipids have also been associated with nuclear matrix regulation139. Interestingly, previous 
studies have shown fluorescent images of a Nile red-stained nucleus but were not discussed. 
Additionally, several spectral images show Nile red associated with the nucleus sharing similar 
spectral properties to Nile red located in the perinuclear and cytoplasmic regions of the same 
cell (Figure 2.4). Therefore, a conclusive statement on this observation cannot be made. While 
the observation is interesting to note and should be further studied, the focus on this thesis is 
not on nucleoplasmic lipids. 
 
The plasma membrane is known to be highly complex and heterogeneous due to the presence 
of different types of lipids, integral proteins and cholesterol within the membrane. The data 
presented here show that spectral phasor analysis can highlight the heterogeneity of the 
plasma membrane region. As studies have shown that Nile Red can interact with other non-
lipophilic macromolecules including proteins, the spectra identified may include Nile Red 
associated with various proteins located within and around the plasma membrane. There is 
insignificant data to accurately identify and differentiate Nile Red associated with various lipids, 




can be further analysed to describe specific sub-regions of the plasma membrane and to show 
how the heterogeneity of the membrane is not consistent between cells.  
 
The significant variances between cells highlight the sensitivity of spectral phasor analysis as a 
single-cell analysis tool. Such sensitivity can prove to lead to incorrect analysis. For example, the 
cells presented in this study are not cell synchronized. Membranes, especially nuclear 
membranes, undergo significant structural changes depending on the stage of the cell cycle. 
This could present challenges as any future observed abnormalities could be the result of a 
membrane altering molecules or because the cell is undergoing mitosis. However, cells in 
different stages of the cell cycle are often identifiable, and therefore some variability in the 
results can be reduced by careful selection of cells with similar morphologies.  
 
Further investigation with Nile Red stained giant unilamellar vesicles (GUV) made up of known 
lipids and cholesterol ratios could allow for the extrapolation of reference Nile Red spectra of 
specific membrane components which can be correlated back to live cell data. Halder et al.134 
determined the emission spectra of Nile Red stained LUV’s comprised of a variety of lipids, but 
obtained λmax values that were significantly greater (632 nm) than the plasma membrane data 
reported here (616 nm). The discrepancy could be a result of temperature differences as the live 
cells were imaged in a cooled room, while Halder et al134 measured at room temperature. Future 
studies should also ensure cell synchronisation is achieved before imaging, and whether there 
are any significant differences in plasma and nuclear membrane microenvironments at different 




2.5 – Conclusion 
The data presented here confirm that the spectral phasor analysis technique can be 
successfully applied to the lipophilic dye Nile Red. Spectral shifts in both λmax and width based on 
the cellular location of Nile Red were observed when using large and small cursors, with the 
latter showing more variance within and between each location and therefore the best method 
for subsequent analysis. Further research may investigate compare Nile Red spectra at various 







Chapter 3 – Spectral phasor analysis of Nile Red spectra 
in discrete subcellular microenvironments 
3.1 – Introduction  
This chapter aims to determine if spectral phasor analysis can successfully distinguish Nile Red 
microenvironments when exposed to monomeric and aggregated amyloids. Plasma and 
nuclear membrane Nile Red microenvironments exposed to monomeric and aggregated Aβ1-42 
and NKB are characterised and compared to determine if each peptide and aggregate type 
interacted with the membranes differently.   
 
3.1.1 – Relationship between astrocytes, Aβ and NKB 
Astrocytes remove any pathogenic material or cellular debris from the environment via 
phagocytosis and promote synaptic plasticity through the release of neurotransmitters such as 
glutamate, γ-aminobutyric acid (GABA), serine, and kynurenic acid140. Astrogliosis occurs when 
astrocytes are activated and are characterised by significant morphological, molecular, and 
proliferative changes. Astrocytes become activated when they identify toxic molecules in the 
CNS and are identified by their hypertrophic morphology and an increase in glial fibrillary acidic 
protein (GFAP) expression140. In AD, reactive astrocytes are found surrounding Aβ plaques, 
expressing Aβ-binding receptors and releasing proinflammatory cytokines. Aβ can induce a 




of interferon-alpha and beta (IFNα, IFNβ), followed by increased levels of pro-inflammatory IL-
1β and IL-6140, 141.  
Neuroinflammation occurs when astrogliosis is uncontrolled, and the continual secretion of 
proinflammatory cytokines induces neuronal and astrocytic insult and death. Non-toxic 
concentrations of Aβ induce indirect neuronal death through the release of proinflammatory 
cytokines from nearby activated astrocytes142, 143. Neuroinflammation occurs when the 
phagocytic capabilities of astrocytes are impaired, rather than the increased production of Aβ. 
In AD, intraneuronal populations of Aβ originates from APP production and the endocytosis of 
exogenous Aβ into endosomes/lysosomes. Accumulation in lysosomes induces membrane 
permeability and leakage of lysosomal contents into the cytoplasm, triggering apoptosis and 
necrosis144.  
 
Interactions between NKB and astrocytes are not well understood, nor as to whether NKB does 
promote some form of inflammatory response. NKB does not promote neuroinflammation 
through the activation of CD4+ memory T cells, unlike the tachykinin peptides substance P, and 
Hemokin-1 90. NKB has been reported to be endocytosed by 1321N1 astrocytoma cells through 







3.2 – Methods  
3.2.1 – Peptide preparation 
Aβ1-42 (DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA) and Neurokinin B (NKB; 
DMHDFFVGLM) were purchased from Synpeptide with > 95% purity. Peptides are bought as a 
lyophilised powder. Two methods to prepare aggregates were utilised. The first method 
involved dissolving the lyophilised powder in 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) for 30 
minutes and sonicating for a further 10 minutes. HFIP was subsequently dried off under an N2 
stream until a film was visibly present. The film was further dried in a freeze dryer (Christ alpha 1-
4 Freeze Dryer) before the peptide was solubilised in DMSO. The second method involved 
directly dissolving the powder in HFIP. NKB stocks were prepared using the first method only, 
while Aβ1-42 stocks were prepared using both methods. All stock solutions were stored at -20°C 
until use. 
 
3.2.2 – ThT Fluorescence Assay 
NKB and Aβ1-42 stock solutions prepared were diluted to 200 μM in 1 x PBS. Additionally, 
lyophilised Aβ1-42 was added directly to 1 x PBS. All preparations were incubated with 10 μM ThT 
and done in a black-walled, clear bottom, sterile 96-well microplate (BMG Labtech) at a final 
volume of 200 μL and left to aggregate for 24 - 48 hours at 37°C in a microplate reader 
(FLUOstar OPTIMA microplate reader). The plate was covered in a transparent sealing film and 




nm) filters were used, and measurement occurred through the bottom of the plate. Upon 
completion of each experiment, samples were transferred to a glass vial and stored at -20°C. 
 
3.2.3 – Electron Microscopy 
10 μL of NKB and Aβ1-42 samples prepared from the ThT fluorescence assay was aliquoted onto 
a 300-mesh copper formvar TEM grid. After 10 minutes incubation time, the excess sample was 
carefully wicked off using a kimwipe. The grid was negatively stained with 0.5% (w/v) uranyl 
acetate replacement stain for 20 s. After 20 s, excess sample was wicked off, and the grid was 
cleaned in water for 20 s and left to dry. Images were taken with a Zeiss Merlin FEGSEM at a 30-
kV acceleration voltage. Fibril dimensions were measured using ImageJ (NIH). 
 
3.2.4 – MTT Assay 
Astrocytoma cells (1321N1) were seeded in a 96-well microplate and cultured in media and 
conditions specified in 2.2.1 for three days. They were treated with 10 μM of monomeric and 
aggregated Aβ1-42 and NKB for 1, 6, 12, and 24 hrs. For controls, DMSO equivalent to the highest 
volume of DMSO added in each treatment was added and incubated for 1, 6, 12, and 24 hrs. At 
the end of each incubation, media was removed, and MTT at a concentration of 0.5 mg/mL was 
added to each well for 1 hr. MTT was carefully removed, DMSO was added and thoroughly 
mixed. Samples were measured for absorbance in a microplate reader (FLUOstar OPTIMA 
microplate reader) at 568 nm. Absorbance values for each treatment were averaged and black-




results were done in Prism 8. Statistical analysis was conducted using the post-hoc mean 
comparisons test with Dunnett T3 multiple comparisons corrections from a Brown-Forsythe 
and Welch one-way ANOVA test. All column and raw data are expressed as mean ± SEM 
percentage of cell viability. 
 
3.2.5 – Cell Culture 
1321N1 astrocytoma cells were cultured as specified in 2.2.1 and were treated once they reached 
60% confluency. 
 
3.2.6 – Treatment with monomeric and aggregated Aβ1-42 and NKB 
Astrocytoma (1321N1) cells were treated with 10uM of monomeric and fibrillar aggregates of 
each peptide in individual fluorodish for 6, 12, and 24 hrs before imaging and spectral phasor 
data acquisition. Control cells were treated with DMSO equivalent to the volume of stock 
peptides used to create the fibrils, or volume of monomeric peptides added directly to the cells. 
In all conditions, v/v% DMSO was < 1%. 
 
3.2.7 – Spectral phasor data acquisition 
Spectral phasor data acquisition was performed as specified in 2.2.2 
 
3.2.8 – Spectral Phasor Analysis  




3.3 – Results 
3.3.1 – ThT fluorescence  
Figure 3.1 shows the ThT fluorescence of the two peptides as they aggregated over 20 hrs 
under the first method. ThT fluorescence for NKB increased from 47 RFU to a maximum of 326 
RFU in 4 hrs 20 min, before slowly decreasing until the end of the scan. ThT fluorescence for 
Aβ1-42 increased from 34 RFU to 76 RFU in 5 hrs 10min before fluctuating around that value until 
the end of the scan. ThT fluorescence HFIP-Aβ1-42 in PBS increased from 36 RFU to 145 RFU in 
20hrs (Figure 3.1), while the fluorescence of lyophilised Aβ1-42 directly added to PBS increased 


















Figure 3.1. Aggregation of 200 μM NKB and Aβ1-42 in PBS after 20 hrs. 
(A) ThT fluorescence of Aβ1-42 and NKB (n = 3). (B) EM images of fibrillar NKB, (C) EM images of protofibrillar Aβ1-42. 
Scale bar = 20nm 



























3.3.2 – Electron Microscopy 
EM images of aggregated NKB show a large amount of fibril-like structures (Figure 3.1) with 
several smaller UAR-replacement stained positive aggregates. NKB fibrils had an average 
length of 453.3 ± 242 nm and width of 10 ± 1.4 nm, with fibrils measured at a maximum of 962.9 
nm and as small as 41.7 nm. Aβ1-42 aggregates imaged were profoundly smaller aggregates but 
were structurally similar to descriptions of stained amyloid fibrils (Figure 3.1). These aggregates 
had an average length of 92 ± 40.5 nm and width of 3.2 ± 1 nm. Aggregates as long as 266.1 nm 
and as small as 34.3 nm were measured. These dimensions were similar to that of protofibrillar 
Aβ1-42. 
 
3.3.3 – MTT Assay  
Monomeric Aβ1-42 and NKB induced no significant differences in cell viability at all time points. 
Aggregated forms of both peptides induce similar trends in cell viability over 24 hrs. 
Protofibrillar Aβ1-42 induced an increase in cell viability after 1 hr (100 vs 109.5 ± 5.3%). Cell 
viability reduced after 6 hrs, with the lowest cell viability observed at 12 hours (92.9 ± 7.8% and 
76.2 ± 2.8% for 6 and 12 hrs respectively). After 24 hours, cell viability had mostly recovered 
(93.4 ± 0.3%).  There was a significant difference in cell viability at 12 hrs of Aβ1-42 treatment 
compared to the 1 hr and control treatments (control vs 12 hr: p = 0.0215, 1 hr vs 12 hr: p = 0.0023; 




at 6 hrs (113.5 ± 5.2% and 123.1 ± 9.6% for 1 hr and 6 hrs respectively). Cell viability subsequently 




3.3.4 – Plasma membrane Nile Red spectra  
Plasma membrane Nile Red λmax and spectral width in the presence of monomeric Aβ1-42 
significantly reduced over time (λmax: 619.1 ± 1 nm vs 614.8 ± 0.6 nm, p = 0.0035; spectral width: 
16.6 ± 0.9 nm vs 13.6 ± 0.4 nm, p = 0.0232; Figure 3.3). In contrast when exposed to protofibrillar 
Aβ1-42  λmax values did not change significantly (615.5 ± 0.8 nm vs 613 ± 0.5 nm) but spectral width 
significantly increased (13.8 ± 0.7nm vs 16.6 ± 0.5 nm; p = 0.0291; Figure 3.3) over time.  
 
Monomeric NKB induced no significant change in λmax (620.4 ± 0.8 nm vs 618.5 ± 0.1 nm) and 
spectral width (17.1 ± 0.9 nm vs 16.1 ± 0.4 nm) over time. In contrast, fibrillar NKB induced a 
significant decrease in λmax over time (622.1 ± 0.8 nm vs 614.2 ± 0.8 nm, p < 0.0001; Figure 3.3), 

































Figure 3.2. MTT assay. 
Raw MTT values were subtracted and divided from their specific sample controls to get % cell viability. *p = 0.0215 for protofibrillar 





Comparing the spectral properties of plasma membrane Nile Red between treatments, no 
significant differences in spectral properties were observed between monomeric Aβ1-42 and 
NKB at 14 hrs, but there was a significant difference in both λmax (p = 0.0001) and spectral width 
(p = 0.0004) at 24 hrs (Figure 3.3). Significant differences in plasma membrane λmax between 
aggregated Aβ1-42 and NKB were observed at 14 hrs (p < 0.0001; figure 3.3), but no λmax 
difference was observed at 24hrs (Figure 3.3). No difference in spectral width between the 
aggregated peptides was observed at both 14 and 24 hrs (Figure 3.3). 
 
Spectral variances of plasma membrane Nile Red decreased over time. Specifically, average 
λmax variance decreased from 13.1 nm to 9.7 nm, and spectral width decreased from 10.2 nm to 
7.2 nm. Qualitative analysis confirms that the plasma membrane exhibits increased 





































































































































Figure 3.3. Special properties of plasma membrane Nile Red under exposure to monomeric and aggregated 
Aβ1-42 and NKB. 
(A) λmax and (B) spectral width values of plasma membrane Nile Red using 0.005 sized cursors. Data represented as 
column graph with mean ± SEM. For λmax results: **p = 0.0035, ***p = 0.0001, ***p < 0.0001. For spectral width 






















Figure 3.4. Spectral phasor analysis of plasma membrane Nile Red at 14hrs. 
Plasma membrane Nile Red were isolated in astrocytoma cells treated with (A) monomeric Aβ1-42, (B) protofibrillar 
Aβ1-42, (C) monomeric NKB, and (D) fibrillar NKB for 14 hrs. From left to right: fluorescence image, phasor plot with 


























Cursor colour λmax (nm) Width (nm) 
Figure 3.4A 
Red 625.8 17.8 
Light Green 621.7 15.8 
Dark Blue 626.1 21.3 
Dark Green 615.7 17.7 
Orange 616 13.9 
Yellow 614 12.7 
Pink 610.5 13.2 
   
Figure 3.4B 
Red 611.2 13.3 
Light Green 611.4 15.4 
Dark Blue 616.8 14.4 
Dark Green 614.6 15.5 
Orange 614.1 11.8 
Yellow 616.3 13.1 
Pink 613.1 18.1 
   
Figure 3.4C 
Red 628 11.8 
Light Green 618.9 15.5 
Dark Blue 616.4 15.4 
Dark Green 619 13.4 
Orange 625 12.5 
Yellow 618.4 18.3 
Pink 620.2 14.1 
Brown 617.1 21.6 
Light Blue 617 12 
Black 619.6 12.3 
   
Figure 3.4D 
Red 623.6 15.1 
Light Green 623.8 17.3 
Dark Blue 623.7 13.8 
Dark Green 624.9 14.9 
Orange 625.8 18.5 
Yellow 627.3 22.5 




























Figure 3.5. Spectral phasor analysis of plasma membrane Nile Red at 24hrs. 
Plasma membrane Nile Red were isolated in astrocytoma cells treated with (A) monomeric Aβ1-42, (B) protofibrillar 
Aβ1-42, (C) monomeric NKB, and (D) fibrillar NKB for 24 hrs. From left to right: fluorescence image, phasor plot with 





















Cursor colour λ max (nm) Width (nm) 
Figure 3.5A 
Red 612.9 15.2 
Light Green 613.1 13.7 
Dark Blue 610.9 16.3 
Dark Green 613.5 12.8 
Orange 609.9 14.8 
Yellow 610.1 12.7 
Pink 612.3 18.3 
   
Figure 3.5B 
Red 612 15.6 
Light Green 611.7 14.5 
Dark Blue 613.7 18.3 
Dark Green 613.1 14.3 
Orange 614.7 16.9 
Yellow 612.3 20.3 
   
Figure 3.5C 
Red 615.6 13.7 
Light Green 618.5 14.7 
Dark Blue 619.8 13.7 
Dark Green 611.6 15 
Orange 623.2 15.1 
Yellow 615 16.7 
Pink 619.2 17.4 
   
Figure 3.5D 
Red 614.8 17.3 
Light Green 617.5 17.7 
Dark Blue 624.2 15.8 
Orange 623.2 16.7 




3.3.5 – Perinuclear Nile Red spectra  
Perinuclear Nile Red in the presence of monomeric and protofibrillar Aβ1-42 induced a decrease 
in λmax over time (Figure 3.6). Specifically, monomeric Aβ1-42 exhibited λmax values of 623.0 ± 0.4 
nm, and 619.6 ± 0.8 nm at 14 and 24 hrs, respectively. Protofibrillar Aβ1-42 exhibited λmax values of 
622.9 ± 0.6 nm and 619.4 ± 0.6 nm at 14 and 24 hrs respectively.  
 
Spectral width values did not significantly change over time for both Aβ1-42 species (Figure 3.6). 
Specifically, monomeric Aβ1-42 exhibited spectral width values of 12.0 ± 0.1 nm and 12.0 ± 0.1 nm 
at 14 and 24 hrs, respectively. Protofibrillar Aβ1-42 exhibited spectral width values of 12.0 ± 0.1 nm 
and 12.4 ± 0.1 nm at 14 and 24 hrs respectively.  
 
λmax values of perinuclear Nile Red in the presence of monomeric NKB significantly increased 
over time (p = 0.0229; Figure 3.6). Monomeric NKB exhibited λmax values of 621.7 ± 0.4 nm and 
623.3 ± 0.3 nm at 14 and 24 hrs. Spectral width did not change significantly over time (14hr: 11.8 ± 
0.1 nm; 24 hr: 11.4 ± 0.4 nm; Figure 3.6). λmax values in the presence of fibrillar NKB significantly 
decreased over time (p = 0.0216; Figure 3.6). λmax values were 622.8 ± 0.7 nm and 620.2 ± 0.5 nm 
for 14 and 24 hrs. Spectral width in the presence of fibrillar NKB increased over time (p = 0.0013; 





λmax values between monomeric Aβ1-42 and NKB were only statistically different after 24 hrs 
(Figure 3.4). λmax and spectral width values between aggregated Aβ1-42 and NKB were similar at 






































































































Figure 3.6. Spectral properties of perinuclear Nile Red under exposure of monomeric and aggregated Aβ1-42 
and NKB. 
(A) λmax and (B) spectral width values of perinuclear Nile Red using 0.005 sized cursors. Data represented as column 
graph with mean ± SEM. For λmax results: *p = 0.0229 for monomeric NKB, *p = 0.0216 for fibrillar NKB, **p = 0.0044 





3.3.6 – Nuclear membrane Nile Red spectra  
No difference in λmax (627 ± 0.5 nm vs 625.1 ± 0.8 nm) and spectral width (12.8 ± 0.2 nm vs 12.3 ± 
0.3 nm) in the presence of monomeric Aβ1-42 over time was observed (Figure 3.7, Figure 3.8, 
Figure 3.9, Table 3.3, Table 3.4). Protofibrillar Aβ1-42 induced a significant decrease in λmax (625.7 
± 0.5 nm vs 622.7 ± 0.5 nm, p = 0.0015; Figure 3.7 – 3.9, Table 3.3, Table 3.4) but no significant 
difference in spectral width (12.4 ± 0.2 nm vs 12.7 ± 0.2 nm; Figure 3.7). Monomeric NKB 
exhibited a significant decrease in λmax (628.9 ± 0.51 vs 623.2 ± 0.4, p < 0.0001; Figure 3.7) but no 
significant decrease in spectral width (12.6 ± 0.3 nm vs 11.7 ± 0.2 nm; Figure 3.7) over time. 
Fibrillar NKB exhibited significant decreases in λmax (628.6 ± 0.5 nm vs 622.4 ± 0.38 nm, p < 
0.0001; Figure 3.7) and spectral width significantly increased (11.8 ± 0.1 nm vs 12.7 ± 0.2 nm, p = 
0.0001; Figure 3.7) over time.   
 
λmax and spectral width of monomeric Aβ1-42 and NKB were similar at all time points. At 14 hrs, λmax 
values of aggregated Aβ1-42 and NKB were significantly different (p = 0.002) but were similar at 
24 hrs (Figure 3.7). Spectral width between the two aggregates was similar at all time points. 
Variance in λmax and spectral width increased over time across all treatments (Figure 3.8, Figure 













































































































Figure 3.7. Spectral properties of nuclear membrane Nile Red under exposure of monomeric and aggregated 
Aβ1-42 and NKB. 
(A) λmax and (B) spectral width values of nuclear membrane Nile Red using 0.005 sized cursors. Data represented as 
column graph with mean ± SEM. For λmax results: **p = 0.0015 for protofibrillar Aβ1-42, **p = 0.0020 for protofibrillar 










Figure 3.8. Spectral phasor analysis of nuclear membrane Nile Red at 14 hrs. 
Nuclear membrane Nile Red were isolated in astrocytoma cells treated with (A) monomeric Aβ1-42, (B) fibrillar Aβ1-42, 
(C) monomeric NKB, and (D) fibrillar NKB for 14 hrs. From left to right: fluorescence image, phasor plot with zoomed in 


























Cursor colour λmax (nm) Width (nm) 
Figure 3.8A 
Red 628 12.7 
Light Green 624.2 13.7 
Dark Blue 629 13 
Dark Green 630.2 13.1 
Orange 624.8 13.2 
   
Figure 3.8B 
Red 626.4 11.9 
Light Green 627.8 11.6 
Dark Blue 629.7 12.2 
Dark Green 624.8 12.3 
Orange 625 12.9 
Yellow 623.7 12.9 
   
Figure 3.8C 
Red 629.2 12.1 
Light Green 629.7 12.6 
Dark Blue 628.8 11.6 
Dark Green 627.9 12 
   
Figure 3.8D 
Red 630 11.9 
Light Green 628.4 11 
Dark Blue 626.6 12.2 
Dark Green 628.1 12 
Orange 631.5 11.7 
Yellow 627.7 11.4 




























Figure 3.9. Spectral phasor analysis of nuclear membrane Nile Red at 24 hrs. 
Nuclear membrane Nile Red were isolated in astrocytoma cells treated with (A) monomeric Aβ1-42, (B) fibrillar Aβ1-42, 
(C) monomeric NKB, and (D) fibrillar NKB for 24 hrs. From left to right: fluorescence image, phasor plot with zoomed 


























Cursor colour λmax (nm) Width (nm) 
Figure 3.9A 
Red 625.3 12.1 
Light Green 621.2 13.5 
Dark Blue 623.1 12.5 
Dark Green 619.1 14 
Orange 619.7 12.9 
Yellow 626.6 12.1 
   
Figure 3.9B 
Red 625.1 12.5 
Light Green 624.2 12.4 
Dark Blue 622.1 13.2 
Dark Green 623.3 12.3 
   
Figure 3.9C 
Red 623.6 11.1 
Light Green 621.9 11.4 
Dark Blue 622.8 11.2 
Dark Green 621.6 11.9 
Orange 620.9 12.1 
Yellow 624.8 11.2 
Pink 621.6 12.4 
   
Figure 3.9D 
Red 621.4 14.3 
Light Green 623.8 13.5 
Dark Blue 624.2 12.5 
Dark Green 627.6 13.2 
Orange 626.3 12.3 
Yellow 618.6 13.7 




3.3.7 – Nuclear Nile Red spectra  
λmax (14 hrs: 627.2 ± 0.3 nm, 24 hrs: 625.3 ± 0.6 nm) and spectral width (14 hrs: 14.7 ± 0.2 nm, 24 
hrs: 16.1 ± 0.4 nm) values of nuclear Nile Red were similar over time when exposed to 
monomeric Aβ1-42. λmax values significantly decreased over time (14 hrs: 626.9 ± 0.5 nm, 24 hrs: 
623.9 ± 0.4 nm) in the presence of protofibrillar Aβ1-42, but spectral width were statistically similar 
(14 hrs: 15.1 ± 0.4 nm, 24 hrs: 14.6 ± 0.3 nm; Figure 3.10).  
 
Exposure of monomeric NKB did not affect λmax over time (14 hrs: 625.2 ± 0.4 nm, 24 hrs: 624.3 ± 
0.3 nm) but spectral width significantly decreased (14 hrs: 14.7 ± 0.3 nm, 24 hrs: 11 ± 1 nm). Similar 
patterns in λmax were observed for fibrillar NKB (14 hrs: 626 ± 0.6 nm, 24 hrs: 624.3 ± 0.3 nm), but 
spectral width significantly increased over time (14 hrs: 14.4 ± 0.3 nm, 24 hrs: 17.5 ± 0.5 nm; 
Figure 3.10). 
 
At 14 hrs, nuclear Nile Red λmax values were significantly different in the presence of monomeric 
Aβ1-42 and NKB. A significant difference in spectral width between monomeric Aβ1-42 and NKB 
was only present at 24 hrs. λmax values between the two peptide aggregates were similar at both 
14 and 24 hrs. Spectral width values were only significantly different between both peptide 










































































































Figure 3.10. Spectral properties of nuclear Nile Red under exposure of monomeric and aggregated Aβ1-42 and 
NKB. 
(A) λmax and (B) spectral width values of nuclear Nile Red using 0.005 sized cursors. Data represented as column 
graph with mean ± SEM. For λmax results: **p = 0.0022, ***p = 0.0008. For spectral width results **p = 0.0091, ***p 




3.4 – Discussion  
3.4.1 – Amyloid Beta did not aggregate into mature fibrils  
Figure 3.1 shows that the preparation methods described above were able to produce fibrillar 
NKB. Mature fibrils have a straight, hair-like appearance, several micrometres in length, and 10-
20 nm wide 1, 147. While the prepared NKB aggregates are shorter in length and barely meet the 
minimum fibril diameter dimensions, the morphology of these aggregates is like amyloid fibrils. 
The shorter length and diameter could be due to NKB’s shorter peptide sequence. Additionally, 
only a small population of these aggregates are imaged under EM, so it is possible that the 
larger aggregates were missed. Future research should investigate the structural differences of 
fibrillar amyloidogenic peptides based on their sequence length.  
 
Aβ1-42 prepared in the same conditions produced smaller aggregates, as determined by the 
relatively low ThT fluorescence. STEM images show small curvilinear aggregates that are fibril-
like in their morphology but are significantly smaller in length and width to the characteristic 
amyloid fibril. With these observations, it could be that protofibrillar instead of fibrillar Aβ1-42 were 
formed. Protofibrillar Aβ1-42 was initially characterised by Harper et al.148 using AFM, describing it 
as a being 4-10 nm in diameter and up to 200 nm in length. Walsh et al.149 further characterised 
protofibrillar Aβ and determined that the aggregates contained β-sheet structure and gave rise 
to mature fibrils. Nichols et al.150 described protofibrillar Aβ1-42 aggregates as flexible, curvilinear 
structures that are typically < 200 nm in length with an average length of 78 ± 35 nm. The 




protofibrillar aggregate and combined with the relatively low ThT fluorescence, it can be 
concluded that protofibrillar Aβ1-42 aggregates were formed.  
 
The observation that Aβ1-42 did not form mature fibrils was surprising, given how other studies 
described producing mature fibrils after a few hours in aggregation. However, several studies 
showed the formation of mature fibrils after a few days/weeks. During the early ’90s there were 
significant discrepancies in the toxicity of Aβ1-42. Several researchers linked the differences in 
the individual study’s results to differences in their preparation methodology. While the process 
of preparing lyophilised Aβ1-42 became standardised, the process of preparing monomeric, and 
higher-order aggregates are varied. Research groups develop or modify existing protocols to 
suit the equipment and materials available to them. Variations in aggregation conditions have 
been shown to form structurally different Aβ1-42 fibrils151, but whether the discrepancies had a 
significant impact on their toxicity are unknown. With the conditions described in the 
methodology above, it is possible that the peptide was not given enough time to transition from 
protofibrillar to mature fibrils. Future research should investigate the reasons for this 
discrepancy between incubation times needed for the formation of mature Aβ1-42 fibrils.  
  
Sample preparation could have attributed to the lack of fibril formation for Aβ1-42. To test if 
DMSO influenced its aggregation, monomeric Aβ1-42 were prepared by solubilising lyophilised 
Aβ1-42 in HFIP only and incubated in PBS. Figure 3.1 shows that under these conditions, Aβ1-42 
aggregates have a significantly higher ThT fluorescence compared to those produced using 




shows the presence of a lag curve that lasted 4.5 hrs (Figure 3.1). The aggregation curves of 
both Aβ1-42 and NKB made using the HFIP-DMSO method had no noticeable lag phase.  HFIP is 
an organic solvent that has strong hydrogen bonding affinities, which ensures that any pre-
prepared lyophilised peptide/proteins are soluble and unstructured152. To test whether 
solubilising in HFIP affected its aggregation, lyophilised Aβ1-42 was added directly to the PBS at a 
weight that would equate to 200 μM in solution. Those aggregates had a higher ThT 
fluorescence compared to the aggregates produced using the HFIP-DMSO method but were 
lower than the aggregates producing using the HFIP-only method and NKB (Figure 3.1). No 
noticeable lag phase was present (Figure 3.1). EM images of these alternate prepared 
aggregates were unable to be acquired, so their exact morphology could not be confirmed. 
These results imply that the solubilization through DMSO affects the final aggregation state. 
Future research would investigate which buffers or solutions would consistently and reliably 
produce mature Aβ1-42 fibrils.   
 
3.4.2 – MTT results correlate with expected astrocytic reactions 
MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced to the blue-
coloured insoluble formazan by the mitochondrial enzyme, succinate dehydrogenase. The level 
of formazan is an indicator of the number of cells with functional mitochondria, and thus is a 
reliable indicator of cell viability. The MTT results presented here (Figure 3.2) indicate that the 
most significant difference in cell viability for fibrillar Aβ1-42 and NKB are at 12 hrs and thus 




should focus around this time point. In comparison, other studies have shown using the MTT 
assay that addition of 10 and 20 μM monomeric Aβ1-42 to neuronal cultures induces a significant 
decrease in cell viability153, 154. 
 
The MTT assay is a popular cell viability assay. However, reports have demonstrated the 
unreliability of the assay, particularly in the presence of several compounds. Stepanenko et al.155 
showed that many polypeptides were able to interfere with MTT reduction, thus resulting in 
inconsistent results between the MTT assay and other cell viability assays. They stated that any 
over- and underestimation of cell viability and the significance of such discrepancies depends 
on multiple experimental parameters, including cell line used and time points. Van Tonder et 
al.156  compared the MTT assay to three other cell viability assays, the neutral red uptake (NRU), 
resazurin reduction (RES) and sulforhodamine B (SRB) assays and showed that the most 
significant variations in results were observed for the MTT assay, while the SRB assay provided 
the most reliable results.  
 
3.4.3 – Plasma membrane Nile Red indicative of distinct membrane 
interactions from monomers 
Changes in the spectral properties of plasma membrane Nile Red are indicative of the plasma 
membrane microenvironment. Spectral phasor analysis of Nile Red reveals that the plasma 
membrane microenvironment reacted differently over time to the presence of monomeric Aβ1-




width over time, while monomeric NKB induced no significant changes in either λmax and 
spectral width over time. This data shows that spectral phasor analysis can show changes in the 
plasma membrane microenvironment in the presence of Aβ1-42. These changes could be due to 
a multitude of factors, such as membrane destabilisation, pore formation, receptor activation 
etc. The data also indicates that monomeric NKB did not significantly alter the plasma 
membrane microenvironment. Shahzad et al.146 showed NKB endocytosis 20 minutes after 
initial exposure via the interaction with NK3R. The data above could suggest that all monomeric 
NKB were successfully endocytosed and that the cell returned to a healthy state.   
 
At 14 hrs, both λmax and spectral width values between both monomers were only different at 24 
hrs. This implies that the plasma membrane microenvironments were similar between the two 
treatments at 14 hrs. The only membrane interactions that are consistent between NKB and Aβ1-
42 are receptor interactions. NKB interacts with the NK3R receptor90, 91, 146, while Aβ1-42 
interactions with a multitude of receptors including NMDA and AMPA receptors63, 64, 66, 70, which 








3.4.4 – Fibrillar peptides induce different plasma membrane interactions 
compared to their monomeric counterparts  
 If changes in λmax or spectral width were consistent, it could be concluded that similar events 
were occurring on the plasma membrane between treatments. The membrane interactions of 
protofibrillar Aβ1-42 differs to that of all other treatments. As shown in Figure 3.3, protofibrillar 
Aβ1-42 induced a significant increase in spectral width over time, and fibrillar NKB induces a 
significant reduction in λmax. Gouwens et al.158 reported that microglia rapidly internalised 
protofibrillar Aβ1-42, while they did not respond as rapidly to monomeric Aβ1-42. However, 
astrocytes rapidly internalise monomeric and oligomeric Aβ1-42 with little to no interactions to 
fibrillar Aβ1-42 159, 160. However, without further analysis in a more controlled environment, the 
nature of the type of membrane interactions cannot be accurately determined based on this 
data alone.  
 
Fibrillar NKB induced a reduction in Nile Red plasma membrane λmax similarly to monomeric Aβ1-
42, suggesting that the membrane interactions between these two peptide types are similar. Maji 
et al.89 reported that many peptide hormone fibrils disaggregate over time, so it could be 
possible that NKB disaggregated into monomers and interacted with the membrane in similarly 
to monomeric NKB. λmax values between monomeric and fibrillar NKB were similar at 14 hrs, as 
shown in Figure 3.3. There were no changes to either λmax or spectral width over time in the 
presence of monomeric NKB. In contrast, there was a significant reduction in λmax over time in 




membrane in the presence of monomeric and fibrillar NKB at 14 hrs are similar, the events 
occurring between 14 and 24 hrs are different between the two peptide aggregates.  
 
3.4.5 – Nuclear membrane microenvironments in the presence of 
monomeric and aggregated Aβ1-42 and NKB were similar 
Other than monomeric Aβ1-42, all treatments induced significant decreases in λmax (Figure 3.7). 
Spectral width did not change in response to protofibrillar Aβ1-42 and monomeric NKB. The data 
suggested that events occurring on the nuclear membrane were similar in the presence of 
protofibrillar Aβ1-42 and monomeric NKB.  
 
However, in the presence of monomeric Aβ1-42 and fibrillar NKB, nuclear membrane events are 
similar but not identical. The fact that spectral variances of nuclear membrane Nile Red 
increased over time across all treatments also supports this (Figure 3.8, Figure 3.9). Nuclear 
translocation of ERK1161 and upregulation of the APP162 have been reported to occur in 
astrocytes in response to the presence of Aβ. Once activated by NKB, NK3R does localise with 
nuclear membranes in 1231N1 cells, but the exact mechanisms after this localisation are still 
unknown. Again, the data present here cannot determine the exact events occurring at the 
nuclear membrane in response to all treatments at either 14 or 24 hrs, but it does show that 
similar events are occurring at the nuclear membrane regardless of which amyloidogenic 






The data presented here demonstrate that spectral phasor analysis can identify significant 
differences in the plasma membrane microenvironment in the presence of monomeric and 
aggregated Aβ1-42 and NKB. The nuclear membrane microenvironment was the most consistent 
in terms of spectral shifts, with decreases in λmax over time observed for all peptide and 
aggregate types, except monomeric Aβ1-42. This suggests that despite the type of plasma 
membrane interaction induced by monomeric and aggregated amyloidogenic peptides, it 
inevitably leads to similar events occurring on the nuclear membrane. The data presented here 
alone cannot elucidate the specific events occurring on both plasma and nuclear membranes. 
Changes in the spectral properties of plasma membrane Nile Red in the presence of 
monomeric Aβ1-42 could be due to a multitude of membrane interactions such as membrane 
destabilisation, pore formation, receptor activation etc.  Future research would investigate 
specific membrane interactions, if possible, on model membranes to determine a relationship 






Chapter 4 – Final conclusions 
Amyloidogenic peptides aggregate under a common pathway to form long hair-like 
aggregates, known as amyloid fibrils. Amyloid Beta is the most well-studied amyloidogenic 
protein as its presence in amyloid plaques is considered the pathological hallmark of 
Alzheimer’s Disease, the most common form of dementia. Initial observations presumed that 
the more stable aggregate form, the amyloid fibril constituted for most of the toxicity seen in 
amyloid diseases, but the smaller more soluble oligomers were quickly considered to be the 
significant toxic amyloid species. While the exact mechanisms for Aβ toxicity have not been fully 
elucidated, membrane interactions are believed to be critical to their toxicity40, 163. Several 
amyloidogenic peptides are associated with biological functions and thus are defined as 
functional amyloids. It has been of increasing interest in understanding why some amyloids 
induce toxicity, and others do not. One theory proposes that functional amyloids interact with 
membranes in such a way that they do not cause toxicity. Spectral phasor analysis presents a 
technique that allows us to characterise the local microenvironment in live cells at a resolution 
that cannot be achieved with other methods.  
 
Here, spectral phasor analysis was applied to the lipophilic dye, Nile Red, to measure membrane 
microenvironments in 1321N1 astrocytic cells in the presence of monomeric and aggregated 
forms of Aβ1-42, and the functional amyloidogenic peptide NKB. The dye was first applied to 




discriminating specific Nile Red species in subcellular sections before measurements were 
done with the amyloidogenic peptides.  
 
Conclusion 1: Spectral phasor analysis can successfully differentiate Nile Red species in 
subcellular regions in live cells 
Spectral phasor analysis was able to isolate Nile Red species localised around the plasma 
membrane, perinuclear and nuclear regions in 1321N1 astrocytoma cells and differentiate 
between each region by variances in its spectral properties as shown in Figure 2.3. λmax 
increased as Nile Red localised from the plasma membrane through to the nuclear region with a 
10 nm difference between the two regions. Spectral width of Nile Red narrowed from the 
plasma membrane towards the nuclear region.  
 
Conclusion 2: Membrane heterogeneity was observed in Nile Red stained cells using 
Spectral Phasor Analysis 
Quantitative and qualitative analysis of the three regions revealed that the most significant 
variances of spectral properties were present for Nile Red situated around the plasma 
membrane region. Further qualitative analysis reveals that the level of heterogeneity is not 
consistent between cell to cell as some cells exhibit more homogeneity compared to others 
(Figure 2.3). This was expected as there will always be a level of dissimilarity between cells, but it 





Conclusion 3: Spectral phasor analysis can detect differences in plasma membrane 
microenvironments between monomeric and aggregated Aβ1-42 and NKB 
As shown in Figure 3.3, there were no significant differences in λmax and spectral width of 
plasma membrane Nile Red between monomeric Aβ1-42 and NKB at 14 hrs, but differences were 
observed at 24 hrs. This implies that the plasma membrane microenvironment in the presence 
of monomeric forms of Aβ1-42 and NKB were similar at 14 hrs, but became distinct at 24 hrs, 
highlighting the difference in astrocytic reaction to both peptides. The opposite trend was 
observed for aggregate species of both peptides. At 14 hrs, there were significant differences in 
the λmax of plasma membrane Nile Red in the presence of protofibrillar Aβ1-42 compared to 
fibrillar NKB, but no difference was observed after 24 hrs. Spectral width remained statistically 
similar between each aggregate across all time points.  
 
The data demonstrate that spectral phasor analysis is sensitive enough to differentiate spectral 
shifts of Nile Red at the plasma membrane as a consequence of membrane interactions 
between monomeric and aggregated forms of Aβ1-42 and NKB. 
 
Conclusion 4: Nuclear membrane microenvironments elucidated via spectral phasor 
analysis of Nile Red were similar in the presence of monomeric and aggregated Aβ1-42 
and NKB 
λmax and spectral width values of nuclear membrane Nile Red were consistent across all times 




that regardless of the incubation period, the nuclear membrane environment does not react 
differently to the presence of either peptide. 
 
4.1 – Future Work 
4.1.1 – Spectroscopic analysis of Nile Red using spectral phasor analysis 
The most apparent future work would be to apply spectral phasor analysis to the 
characterisation of Nile Red spectral shifts under specific membrane interactions. Because it is 
currently unknown what specific Nile Red shifts are indicative of, it was impossible to determine 
the exact interactions occurring on the membrane for each peptide and aggregate type. 
Applying spectral phasor analysis to Nile red loaded GUVs and treating them with molecules 
that alter membranes through a specific mechanism will allow correlating specific spectral shifts 
to a membrane interaction. For example, melittin is the main component of bee venom and is a 
26-residue peptide that increases membrane permeability specifically through pore formation.  
 
4.1.2 – Spectral phasor analysis of Laurdan spectra to measure membrane 
microenvironments at the plasma and nuclear membrane level.  
Laurdan is known to induce significantly spectral shifts based on membrane fluidity. Applying 
spectral phasor analysis to Laurdan presence of monomeric and aggregate Aβ1-42 and NKB may 
expand the findings in this thesis with a focus specifically on membrane fluidity. Plasma 




levels of membrane fluidity in a huntingtin disease model. Therefore, it would be expected that 
distinct membrane fluidity changes in the presence of monomeric and fibrillar Aβ1-42 can be 
differentiated by spectral phasor analysis of Laurdan. 
 
4.1.3 – Elucidation of nuclear microenvironments using Nile Red 
The presence of Nile Red within the nucleus was an exciting observation but could not be 
explored further as it was out of the scope of this thesis. Fluorescence microscopy studies using 
Nile Red primarily focused on cytoplasmic, and plasma and nuclear membranes, with no 
investigations focusing on the presence of Nile Red fluorescence within the nucleus. Perhaps 
those researchers believed that the appearance of such fluorescence was an abnormality or 
was background fluorescence. However, the results presented in both chapters 2 and 3 
showed that nuclear Nile Red exhibited spectral properties that were consistent with 
cytoplasmic Nile Red and did undergo spectral shifts in the presence of the amyloidogenic 
peptides. The presence of lipids within the nucleus is well known, and they have been reported 
to be involved in controlling proliferation and gene expression.  
 
4.1.4 – Lipid microenvironments in the presence of other amyloidogenic 
peptides 
Membrane interactions of several toxic amyloidogenic peptides have been elucidated and 
possess similarities to those exhibited by Aβ1-42. Oligomeric forms of alpha-synuclein (As) and 




receptors to induce neuronal insult164. Elongation of As and hIAPP aggregates on the 
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Figure A1.1. Referencing a Leica file.  
To reference a file created on a Leica software, the FLIM window is first opened by pressing ‘FLIM’ on the 
SimFCS window (A). Next, the Lifetime form window is opened by pressing ‘Lifetime form’ (B). (C) The 
reference spectra files button is located under the ‘File’ dropdown menu. Setting the start and end 
wavelength of the XYλ scan (red box) before referencing the spectra files is optional, but has to be done 



































   





















Figure A2.1. Average λ max and width values compared between large and small cursors. Box plots of λmax 
and spectral width values of Nile Red stained 1321N1 (n=8) cells at particular regions of the cell which were 





Appendix 3 – Plasma membrane Nile Red species analysed 






















Figure A3.1 Nile red microenvironments around the plasma membrane. From left to right: 
fluorescence image, phasor plot with zoomed-in inset, and spectral image. All cursor sizes are 0.005. 




Appendix 4 – λmax and spectral width values for each cursor on 
the phasor plots shown in Appendix 3 
 
Cursor colour λmax (nm) Width (nm) 
Figure A3.1A 
Red 620.6 19.9 
Light Green 623 20.6 
Dark Blue 620.5 21.6 
   
Figure A3.1B 
Red 614.8 25.4 
Light Green 611.5 22.8 
Dark Blue 617.5 18.7 
Dark Green 612.2 20.8 
Orange 618.8 24.3 
   
Figure A3.1C 
Red 613.9 17.1 
Light Green 616.8 17.8 
Dark Blue 618.5 18.3 
   
Figure A3.1D 
Red 609.6 16.4 
Light Green 613.4 17.8 
Dark Blue 621.1 31.5 
Dark Green 617.7 16.4 
Orange 614.3 15.4 
   
Figure A3.1E 
Red 621.7 16.9 
Light Green 619.6 15.3 
Dark Blue 618.6 18.2 
Dark Green 617.6 17.1 
Orange 621.4 20.4 
Yellow 623 20.7 
   
Figure A3.1F 
Red 613.3 19 
Light Green 612.3 17 
Dark Blue 610.5 17.7 
Orange 619.3 20.7 
Yellow 622.4 21.9 





Red 616.4 16.8 
Light Green 618.5 17.5 
Dark Blue 617.4 20.6 
Dark Green 619.5 15.7 
   
Figure A3.1H 
Red 620.8 17.7 
Light Green 612.6 19.1 
Dark Blue 619.4 19.3 






Appendix 5 – Plasma membrane Nile Red species after 14 hr 

































Figure A5.1. Spectral phasor analysis of plasma membrane Nile Red at 14hrs. Nile red species 
located close to the plasma membrane region were isolated in astrocytoma cells treated with (A,C,E) 
monomeric Aβ1-42 ,(G,I,K) protofibrillar Aβ1-42, (B,D,F) monomeric NKB, and (H,J,L) fibrillar NKB for 14 
hrs. From left to right: fluorescence image, phasor plot with zoomed in inset, and spectral image. Scale 




Appendix 6 – λmax and spectral width values for each cursor on 
the phasor plots shown in Appendix 5 
 
Cursor colour λmax (nm) Width (nm) 
Figure A5.1A 
Red 625.8 17.8 
Light Green  621.7 15.8 
Dark Blue 626.1 21.3 
Dark Green 615.7 17.7 
Orange 616 13.9 
Yellow 614 12.7 
Pink 610.5 13.2 
   
Figure A5.1B 
Red 628 11.8 
Light Green 618.9 15.5 
Dark Blue 616.4 15.4 
Dark Green 619 13.4 
Orange 625 12.5 
Yellow 618.4 18.3 
Pink 620.2 14.1 
Brown 617.1 21.6 
Light Blue 617 12 
Black 619.6 12.3 
   
Figure A5.1C 
Red 623.3 20.1 
Light Green 621.3 22.7 
Dark Blue 623.1 17.9 
Dark Green 618.1 24.6 
   
Figure A5.1D 
Red 615.3 17.1 
Light Green 618.9 19.3 
Dark Blue 615.9 16 
Dark Green 620 23.3 
Orange 623.4 25.2 
Yellow 615.1 14.6 
Pink 613.7 18.1 
Brown 618.3 16.5 
Light Blue 626.3 31.3 
   





Red 623.3 20.1 
Light Green 621.3 22.7 
Dark Blue 623.1 17.9 
Dark Green 618.1 24.6 
   
Figure A5.1F 
Red 624.2 13.5 
Light Green 622.2 14.8 
Dark Blue 623.3 17.1 
Dark Green 624.4 18.6 
Orange 622.5 24.9 
Yellow 618.1 23.7 
Pink 613.8 19.4 
Figure A5.1G 
Red 618.7 12.2 
Light Green 619 10.2 
Dark Blue 618 10.2 
Dark Green 618.1 11.7 
Orange 617.6 10 
Yellow 617.6 12.6 
Pink 614.6 12 
Brown 616.1 11.3 
Light Blue 618.7 13.6 
   
Figure A5.1H 
Red 623.6 15.1 
Light Green 623.8 17.3 
Dark Blue 623.7 13.8 
Dark Green 624.9 14.9 
Orange 625.8 15.8 
Yellow 627.3 22.5 
   
Figure A5.1I 
Red 611.2 13.3 
Light Green 611.4 15.4 
Dark Blue 616.8 14.4 
Dark Green 614.6 15.5 
Orange 615.1 11.8 
Yellow 616.3 13.1 
Pink 613.1 18.1 
   
   
   





Red 617.5 13.7 
Light Green 621.9 15.8 
Dark Blue 624.1 18 
Dark Green 619.4 16.5 
Orange 620.5 14.6 
Yellow 618.2 16.8 
   
Figure A5.1K 
Red 607..9 14.1 
Light Green 610.4 14.4 
Dark Blue 611.2 16.3 
Dark Green 622.9 25.1 
   
Figure A5.1L 
Red 620.2 15.6 
Light Green 622.2 16.4 






Appendix 7 – Plasma membrane Nile Red species after 24hr 








Figure A7.1. Spectral phasor analysis of plasma membrane Nile Red at 24 hrs. Nile red species 
located close to the plasma membrane region were isolated in astrocytoma cells treated with (A,C,E) 
monomeric Aβ1-42, (G,I,) protofibrillar Aβ1-42, (B,D,F) monomeric NKB, and (H,J,L) fibrillar NKB for 24 
hrs. From left to right: fluorescence image, phasor plot with zoomed in inset, and spectral image. Scale 




Appendix 8 – λmax and spectral width values for each cursor on 
phasor plots shown in Appendix 7 
 
Cursor colour λmax (nm) Width (nm) 
Figure A7.1A 
Red 619 12.3 
Light Green 619 14 
Dark Blue 616.9 13.5 
Dark Green 616.1 11.5 
Orange 616.5 14.7 
Yellow 617.3 12.7 
Pink 615.1 12 
   
Figure A7.1B 
Red 615.6 13.7 
Light Green 618.5 14.7 
Dark Blue 619.8 13.7 
Dark Green 611.6 15 
Orange 623.2 15.1 
Yellow 615 16.7 
Pink 619.2 17.4 
   
Figure A7.1C 
Red 612.9 15.2 
Light Green 613.1 13.7 
Dark Blue 610.9 16.3 
Dark Green 613.5 12.8 
Orange 619.9 14.8 
Yellow 610.1 12.7 
Pink 612.3 18.3 
   
Figure A7.1D 
Red 615.5 14.2 
Light Green 620.2 14.6 
Dark Blue 616.7 14.9 
Dark Green 614.6 13.4 
Orange 621.8 16.3 
Yellow 615.7 17.6 
Pink 613.4 15.5 
   




   
Figure A7.1E 
Red 614.4 14.5 
Light Green 616.1 13.5 
Dark Blue 615.5 11.5 
Orange 616.5 15.4 
Yellow 617.4 12.4 
Pink 613.5 12.6 
Light Blue 615.5 11.5 
   
Figure A7.1F 
Red 623.3 13.6 
Light Green 619.7 13.2 
Dark Blue 619.1 16.8 
Dark Green 616.3 18.8 
Orange 613.8 15.2 
Yellow 616 16.5 
   
Figure A7.1G 
Red 612 15.6 
Light Green 611.7 14.5 
Dark Blue 613.7 18.3 
Dark Green 613.1 14.3 
Orange 614.7 16.9 
Yellow 612.3 20.3 
   
Figure A7.1H 
Red 616.4 17.1 
Light Green 615.3 15.2 
Dark Blue 615.9 18.6 
Dark Green 612.8 15.8 
Orange 610.9 17 
Light Blue 612.7 20.1 
   
Figure A7.1I 
Red 611.7 16.2 
Light Green 610.6 14.6 
Dark Blue 614.7 16.2 
Dark Green 613 18.1 
Orange 616.2 19.3 
Yellow 615.7 14.9 
Pink 609.8 16.3 
   
   




   
Figure A7.1J 
Red 615.3 20.1 
Light Green 612.9 21.1 
Dark Blue 613.1 16.4 
Dark Green 616.3 17.7 
Orange 611.7 18.3 
Yellow 620 25.2 
Pink 625.6 23.9 
   
Figure A7.1K 
Red 614.8 17.3 
Light Green 617.5 17.7 
Dark Blue 624.2 15.8 
Orange 623.2 16.7 
Yellow 621.5 17 






Appendix 9 – Perinuclear Nile Red after 14 hr exposure to 












Figure A9.1. Spectral phasor analysis of perinuclear Nile Red at 14 hrs. Perinuclear Nile Red were 
isolated in astrocytoma cells treated with (A,C,E) monomeric Aβ1-42, (G,I,K) protofibrillar Aβ1-42, (B,D,F) 
monomeric NKB, and (H,J,L) fibrillar NKB for 14 hrs. From left to right: fluorescence image, phasor plot 




Appendix 10 – λmax and spectral width values for each cursor on 
phasor plots shown in Appendix 9 
 
 
Cursor colour λmax (nm) Width (nm) 
Figure A9.1A 
Red 624.5 12.6 
Light Green 624.1 11.9 
Dark Blue 622.9 11.6 
Dark Green 625.9 12.6 
Orange 627.4 12.5 
Yellow 625.4 11.5 
Pink 621.5 12 
   
Figure A9.1B 
Red 626.1 13.1 
Light Green 623.8 13.1 
Dark Blue 623.4 12.4 
Dark Green 623.6 11.6 
Orange 625.1 12.5 
Yellow 621.3 13.3 
Pink 622.4 12 
Brown 621.6 11.4 
Light Blue 619.9 11.6 
Black 618.8 11.4 
   
Figure A9.1C 
Red 623.1 11.8 
Light Green 624.7 12.1 
Dark Blue 621.7 12.3 
Dark Green 624.9 11.5 
Orange 623.9 11.2 
Yellow 621.9 11.5 
Pink 620.2 11.6 
Brown 618.6 12.2 
Light Blue 621.2 13.6 
Black 623.4 12.9 
   
   
   
   





Red 623.3 12.6 
Light Green 622.5 11.7 
Dark Blue 620.6 11.8 
Dark Green 621.6 11.2 
Orange 619.9 12 
Yellow 617.7 12 
Pink 621.9 12.3 
Brown 624.8 12.1 
   
Figure A9.1E 
Red 624.5 12 
Light Green 626.5 11.7 
Dark Blue 623.4 11.7 
Dark Green 622.7 12.2 
Orange 621.6 11.7 
Yellow 621.2 12.5 
Pink 622.4 11.4 
Brown 625.4 11.1 
   
Figure A9.1F 
Red 623.7 11.5 
Light Green 624.6 11.7 
Dark Blue 622.2 11.1 
Dark Green 624.9 10.9 
Orange 625.8 11.3 
Yellow 621 10.9 
Pink 620.6 11.8 
Brown 619.3 11.6 
Light Blue 619.7 12.1 
   
Figure A9.1G 
Red 623.9 12.2 
Light Green 624.6 11.8 
Dark Blue 622.3 11.8 
Dark Green 619.9 12.6 
Orange 619.8 11.5 
   
Figure A9.1H 
Red 625.1 11.5 
Light Green 626.4 11 
Dark Blue 626.6 12.2 
Dark Green 628.1 12 
Orange 623.7 11.7 




Pink 623.7 11.2 
   
Figure A9.1I 
Red 623 11.8 
Light Green 624.4 11.4 
Dark Blue 622.1 11.8 
Dark Green 624.8 12.3 
Orange 625 12.9 
Yellow 623.7 12.9 
Pink 620.2 11.9 
Brown 618.7 11 
   
Figure A9.1J 
Red 622 12.2 
Light Green 626.5 12.3 
Dark Blue 625.1 11.8 
Dark Green 624.6 12.7 
Orange 623.1 11.8 
Yellow 621.1 11.6 
Pink 619.5 12 
Brown 618 12.2 
Light Blue 617.4 11.8 
Black 615.9 12.6 
   
Figure A9.1K 
Red 625.7 12.1 
Light Green 624.6 12 
Dark Blue 624.3 12.6 
   
Figure A9.1L 
Red 622.3 12.1 
Light Green 625.5 12.2 
Dark Blue 621.3 11.3 
Dark Green 619.6 11.7 
Orange 618.1 11.9 
Yellow 621.5 12.9 
Pink 623.6 11.7 
Brown 622.8 11.1 





Appendix 11 – Perinuclear Nile Red after 24 hr exposure to 








Figure A11.1. Spectral phasor analysis of perinuclear Nile Red at 24 hrs. Perinuclear Nile Red were 
isolated in astrocytoma cells treated with (A,C) monomeric Aβ1-42, (E,G) protofibrillar Aβ1-42, (B,D) 
monomeric NKB, and (F,H) fibrillar NKB for 24 hrs. From left to right: fluorescence image, phasor plot 




Appendix 12 – λmax and spectral width values for each cursor on 
the phasor plots shown in Appendix 11 
 
Cursor colour λmax (nm) Width (nm) 
Figure A11.1A 
Red 619.4 12.3 
Light Green 621.4 12.1 
Dark Blue 618 12.1 
Dark Green 620.6 11.6 
Orange 622.6 12.9 
Yellow 616.6 12.5 
Pink 613.2 12 
Light Blue 618.3 11.4 
   
Figure A11.1B 
Red 621.6 11.8 
Light Green 623.8 11.5 
Yellow 620.1 11.7 
Pink 622.8 11.7 
   
Figure A11.1C 
Red 622.6 12.4 
Light Green 620.6 11.7 
Dark Blue 622.5 11.2 
Dark Green 619.5 12.3 
   
Figure A11.1D 
Red 624.3 11.3 
Light Green 623.7 11.7 
Dark Blue 623.4 12.4 
Dark Green 624.8 12.1 
Orange 622.3 12.2 
   
Figure A11.1E 
Red 623.6 12.3 
Light Green 622.3 12.3 
Dark Blue 621.1 12.4 
Dark Green 619.4 12.2 
Orange 618.4 12.9 
Yellow 617 12.8 
Pink 622.5 13.5 




Brown 615.9 12.6 
Light Blue 620.3 13.3 
Black 617.7 12.1 
   
Figure A11.F 
Red 622.6 13.3 
Light Green 625.8 13.4 
Dark Blue 621.1 12.4 
Dark Green 623.5 13.3 
Orange 622.9 12.2 
Yellow 625.1 12.3 
Pink 619.1 12.6 
Brown 618.6 11.8 
Light Blue 622.4 11.9 
   
Figure A11.G 
Red 622.5 12.2 
Light Green 620.5 12.2 
Dark Blue 619.5 12.1 
Dark Green 618.4 12.3 
Orange 617.9 11.8 
Yellow 616.6 12 
Pink 615.8 11.9 
   
Figure A11.H 
Red 619.3 12.6 
Light Green 616.9 12.8 
Orange 620.9 13 
Yellow 623.4 12.1 
Pink 620.7 11.9 








Appendix 13 – Nuclear membrane Nile Red after 14hr exposure 









Figure A13.1. Spectral phasor analysis of nuclear membrane Nile Red at 14hrs. Nuclear membrane 
Nile Red were isolated in astrocytoma cells treated with (A,C,E) monomeric Aβ1-42, (F,H,J) protofibrillar 
Aβ1-42, (B,D) monomeric NKB, and (G,I) fibrillar NKB for 14 hrs. From left to right: fluorescence image, 




Appendix 14 – λmax and spectral width values for all cursors on 




Cursor colour λmax (nm) Width (nm) 
Figure A13.1A 
Red 628.3 12.1 
Light Green 628 11.5 
Dark Blue 629.2 12.1 
Dark Green 625.9 12.6 
Orange  627.4 12.5 
   
Figure A13.1B 
Red 626.9 11.8 
Light Green 627 12.6 
Dark Blue 630.8 13.6 
Dark Green 631.3 14.4 
Orange 628.8 12.5 
   
Figure A13.1C 
Red 625.5 12.6 
Light Green 624.6 13.4 
Dark Blue 626.7 13 
Dark Green 625.9 13.6 
   
Figure A13.1D 
Red 629.2 12.1 
Light Green 629.7 12.6 
Dark Blue 628.8 11.6 
Dark Green 627.9 12 
   
Figure A13.1E 
Red 628 12.7 
Light Green 624.2 13.7 
Dark Blue 629 13 
Dark Green 630.2 13.1 
Orange 624.8 13.2 
   
Figure A13.1F 
Red 625.9 12.6 
Light Green 624.4 13.7 




Dark Blue 625.8 13.3 
Dark Green 627.6 12.1 
   
Figure A13.1G 
Red 630 11.9 
Light Green 628.4 11 
Dark Blue 626.6 12.2 
Dark Green 628.1 12 
Orange 631.5 11.7 
Yellow 627.7 11.4 
   
Figure A13.1H 
Red 626.4 11.9 
Light Green 627.8 11.6 
Dark Blue 629.7 12.2 
Dark Green 624.8 12.3 
Orange  625 12.9 
Yellow 623.7 12.9 
   
Figure A13.1I 
Red 629.3 12.1 
Light Green 627.3 12.1 
Dark Blue 627.1 11.3 
Dark Green 630.3 12 
   
Figure A13.1J 
Red 626.6 12.5 
Light Green 624.6 14.3 
Dark Blue 625.9 11.4 
Dark Green 624.7 10.6 
Orange 621.9 11.6 
Yellow 626.8 11.7 





Appendix 15 – Nuclear membrane Nile Red after 24 hr exposure 







Figure A15.1. Spectral phasor analysis of nuclear membrane Nile Red at 24 hrs. Nile red species 
located close to the plasma membrane region were isolated in astrocytoma cells treated with (A,C) 
monomeric Aβ1-42, (E,G) protofibrillar Aβ1-42, (B,D) monomeric NKB, and (F,H) fibrillar NKB for 24 hrs. 
From left to right: fluorescence image, phasor plot with zoomed in inset, and spectral image. Scale bar 




Appendix 16 – λmax and spectral width values for all cursors on 
the phasor plots shown in Appendix 15 
 
Cursor colour λmax (nm) Width (nm) 
Figure A15.1A 
Red 626.3 12.9 
Light Green 626.4 12.2 
Dark Blue 627.1 13.9 
Dark Green 629.6 10.5 
Orange 624 11 
Yellow 628.1 10.7 
Pink 625.8 10.8 
Brown 624.1 14 
Light Blue 626 11.7 
Black 628.9 11.5 
   
Figure A15.1B 
Red 623.6 11.1 
Light Green 621.9 11.4 
Dark Blue 622.8 11.2 
Dark Green 621.6 11.9 
Orange 620.9 12.1 
Yellow 624.8 11.2 
Pink 621.6 12.4 
   
Figure A15.1C 
Red 625.3 12.1 
Light Green 621.2 13.5 
Dark Blue 623.1 12.5 
Dark Green 619.1 14 
Orange 619.7 12.9 
Yellow 626.6 12.1 
   
Figure A15.1D 
Red 625.3 11.2 
Light Green 624 11.1 
Dark Blue 623.2 11.6 
Orange  624.4 12.5 
Yellow 623.7 12.1 
   
   





Red 623.6 12.3 
Light Green 622.3 12.3 
Dark Blue 621.1 12.4 
Pink 622.5 13.5 
Light Blue 620.3 13.3 
   
Figure A15.1F 
Red 622.6 13.3 
Light Green 625.8 13.4 
Dark Blue 621.1 12.4 
Dark Green 623.5 13.3 
Orange 622.9 12.2 
Yellow 625.1 12.3 
Pink 619.1 12.6 
Brown 618.6 11.8 
Light Blue 622.4 11.9 
   
Figure A15.1G 
Red 625.1 12.5 
Light Green 624.2 12.4 
Dark Blue 622.1 13.2 
Dark Green 623.3 12.3 
   
Figure A15.1H 
Red 621.4 14.3 
Light Green 623.8 13.5 
Dark Blue 624.2 12.5 
Dark Green 627.6 13.2 
Orange 626.3 12.3 
Yellow 618.6 13.7 







Appendix 17 – Nuclear Nile Red after 14 hr exposure to 
monomeric and aggregated Aβ1-42 and NKB 
 






Figure A5.1. Spectral phasor analysis of nuclear Nile Red at 14 hrs. Nuclear Nile Red were isolated 
in astrocytoma cells treated with (A,C,E) monomeric Aβ1-42, (G,I,K) protofibrillar Aβ1-42, (B,D,F) 
monomeric NKB, and (H,J,L) fibrillar NKB for 14 hrs. From left to right: fluorescence image, phasor plot 




Appendix 18 – λmax and spectral width values for all cursors on 
the phasor plots shown in Appendix 17 
 
 
Cursor colour λmax (nm) Width (nm) 
Figure A17.1A 
Red 627.4 14.1 
Light Green 627.2 15.4 
Dark Blue 625.8 13.9 
Dark Green 628 13.3 
Orange 625.5 15.6 
Yellow 628.7 14.6 
Pink 629.1 16.1 
   
Figure A17.1B 
Red 625 17.3 
Light Green 625.4 14.8 
Dark Blue 623.9 14.8 
Dark Green 621.7 15.5 
Orange 625.9 16.4 
Yellow 627.5 15.6 
Pink 627.1 17.3 
   
Figure A17.1C 
Red 626.8 15.8 
Light Green 625.9 14.7 
Dark Blue 626.9 13.6 
Dark Green 628.4 15.3 
Orange 624.8 15.8 
   
Figure A17.1D 
Red 623.9 14.4 
Light Green 622.2 14.8 
Dark Blue 621.8 13.3 
Dark Green 623.6 12.9 
Orange 625.1 15.8 
Yellow 626.2 15.4 
   
Figure A17.1E 
Red 627.1 14.2 
Light Green 627.6 15.3 
Dark Blue 626.1 14.6 




Dark Green 627.7 13.3 
Orange 628.7 14.5 
   
Figure A17.1F 
Red 626 12.7 
Light Green 624.8 13.1 
Dark Blue 626.1 13.7 
Dark Green 625.3 14.6 
Orange 626.3 15.2 
Yellow 628.1 14.1 
Pink 627.3 14.8 
Light Blue 626.1 12 
   
Figure A17.1G 
Red 628.4 15.4 
Light Green 625.8 15.7 
Dark Blue 625.7 14.1 
Dark Green 627.4 14 
Orange 628.5 14.5 
   
Figure A17.1H 
Red 628.1 14.3 
Light Green 629 15.4 
Dark Blue 629.5 14.5 
Dark Green 629.5 13.2 
   
Figure A17.1I 
Red 626.1 14.4 
Light Green 626.7 15.8 
Dark Blue 624.4 14.7 
Dark Green 622.7 14.4 
Orange 628.1 14.9 
Yellow 627.2 16.9 
   
Figure A17.1J 
Red 627.8 14 
Light Green 627.8 12.8 
Dark Blue 626.3 12.8 
Dark Green 625.5 12.2 
Orange 625.5 13.7 
Yellow 624.7 13.8 
Pink 626.4 14.9 
   
   





Red 628.8 14.9 
Light Green 629 16.6 
Dark Blue 627.3 15.5 
   
Figure A17.1L 
Red 623.8 15.7 
Light Green 622.8 14.2 
Dark Blue 622 15.4 
Dark Green 624.5 13.8 
Orange 623.8 17.1 
Yellow 625 16 






Appendix 19 – Nuclear Nile Red after 24 hr exposure to 














Figure A19.1. Spectral phasor analysis of Nuclear Nile Red at 24 hrs. Nuclear Nile Red were 
isolated in astrocytoma cells treated with (A,C) monomeric Aβ1-42, (E,G) protofibrillar Aβ1-42, (B,D) 
monomeric NKB, and (F,H,I) fibrillar NKB for 24 hrs. From left to right: fluorescence image, phasor plot 




Appendix 20 – λmax and spectral width values for each cursor 
shown in Appendix 19 
 
Cursor colour λmax (nm) Width (nm) 
Figure A19.1A 
Red 626.8 15.2 
Light Green 628.1 16.9 
Dark Blue 626.1 16.4 
Light Blue 626 13.7 
   
Figure A19.1B 
Red 623 11.8 
Light Green 624.5 11.7 
   
Figure A19.1C 
Red 623.9 16.2 
Light Green 624.4 18.1 
Dark Blue 621.8 16 
Dark Green 623.2 15 
Orange 626.1 15.7 
Yellow 626.3 17.4 
   
Figure A19.1D 
Red 624.4 11.5 
Dark Green 625.3 11.7 
   
Figure A19.1E 
Red 623.2 15.2 
Light Green 624.5 14.8 
Yellow 625.6 15.1 
   
Figure A19.1F 
Red 625.2 15.9 
Light Green 625.5 17.3 
Light Blue 623.7 18.8 
   
Figure A19.1G 
Red 623.8 14.4 
Light Green 624.2 15.4 
Dark Blue 624.4 13.4 
Dark Green 622 13.5 




Orange 625.2 14.2 
Yellow 622 15.2 
   
Figure A19.1H 
Red 625.1 16.3 
Light Green 626.4 17.4 
Orange 625.5 15.2 
Yellow 623.8 15.2 
   
Figure A19.1I 
Red 624.9 14.5 
Light Green 624 15.5 
Dark Blue 625.7 13.8 
Orange 624.7 13.2 
Yellow 623.6 13.2 
 
